04 Nelson Learning & Developmental Disorders
04 Nelson Learning & Developmental Disorders
Language
Language is one of the most critical and complex cognitive functions and can be
broadly divided into receptive (auditory comprehension/understanding) and
expressive (speech and language production and/or communication) functions.
Children who primarily experience receptive language problems may have
difficulty understanding verbal information, following instructions and
explanations, and interpreting what they hear. Expressive language weaknesses
can result from problems with speech production and/or problems with higher-
level language development. Speech production difficulties include oromotor
problems affecting articulation, verbal fluency, and naming. Some children have
trouble with sound sequencing within words. Others find it difficult to regulate
the rhythm or prosody of their verbal output. Their speech may be dysfluent,
hesitant, and inappropriate in tone. Problems with word retrieval can result in
difficulty finding exact words when needed (as in a class discussion) or
substituting definitions for words (circumlocution).
The basic components of language include phonology (ability to process and
integrate the individual sounds in words), semantics (understanding the meaning
of words), syntax (mastery of word order and grammatical rules), discourse
(processing and producing paragraphs and passages), metalinguistics (ability to
think about and analyze how language works and draw inferences), and
pragmatics (social understanding and application of language). Children who
evidence higher-level expressive language impediments have trouble
formulating sentences, using grammar acceptably, and organizing spoken (and
possibly written) narratives.
To one degree or another, all academic skills are taught largely through
language, and thus it is not surprising that children who experience language
dysfunction often experience problems with academic performance. In fact,
some studies suggest that up to 80% of children who present with a specific
learning disorder also experience language-based weaknesses. Additionally, the
role of language in executive functioning cannot be understated, since language
serves to guide cognition and behavior.
Visual-Spatial/Visual-Perceptual Function
Important structures involved in the development and function of the visual
system include the retina, optic cells (e.g., rods and cones), the optic chiasm, the
optic nerves, the brainstem (control of automatic responses, e.g., pupil dilation),
the thalamus (e.g., lateral geniculate nucleus for form, motion, color), and the
primary (visual space and orientation) and secondary (color perception) visual
processing regions located in and around the occipital lobe. Other brain areas,
considered to be outside of the primary visual system, are also important to
visual function, helping to process what (temporal lobe) is seen and where it is
located in space (parietal lobe). It is now well documented that the left and right
cerebral hemispheres interact considerably in visual processes, with each
hemisphere possessing more specialized functions, including left hemisphere
processing of details, patterns, and linear information and right hemisphere
processing of the gestalt and overall form.
Critical aspects of visual processing development in the child include
appreciation of spatial relations (ability to perceive objects accurately in space
in relation to other objects), visual discrimination (ability to differentiate and
identify objects based on their individual attributes, e.g., size, shape, color, form,
position), and visual closure (ability to recognize or identify an object even
when the entire object cannot be seen). Visual-spatial processing dysfunctions
are rarely the cause of reading disorders, but some investigations have
established that deficits in orthographic coding (visual-spatial analysis of
character-based systems) can contribute to reading disorders. Spelling and
writing can emerge as a weakness because children with visual processing
problems usually have trouble with the precise visual configurations of words. In
mathematics, these children often have difficulty with visual-spatial orientation,
with resultant difficulty aligning digits in columns when performing calculations
and difficulty managing geometric material. In the social realm, intact visual
processing allows a child to make use of visual or physical cues when
communicating and interpreting the paralinguistic aspects of language. Secure
visual functions are also necessary to process proprioceptive and kinesthetic
feedback and to coordinate movements during physical activities.
Intellectual Function
A useful definition of intellectual function is the capacity to think in the
abstract, reason, problem-solve, and comprehend. The concept of intelligence
has had many definitions and theoretical models, including Spearman's unitary
concept of “the g-factor,” the “verbal and nonverbal” theories (e.g., Binet,
Thorndike), the 2-factor theory from Catell (crystallized vs fluid intelligence),
Luria's simultaneous and successive processing model, and more recent models
that view intelligence as a global construct composed of more-specific cognitive
functions (e.g., auditory and visual-perceptual processing, spatial abilities,
processing speed, working memory).
The expression of intellect is mediated by many factors, including language
development, sensorimotor abilities, genetics, heredity, environment, and
neurodevelopmental function. When an individual's measured intelligence is >2
standard deviations below the mean (a standard score of <70 on most IQ tests)
and accompanied by significant weaknesses in adaptive skills, the diagnosis of
intellectual disability may be warranted (see Chapter 53 ).
Functionally, some common characteristics distinguish children with deficient
intellectual functioning from those with average or above-average abilities.
Typically, those at the lowest end of the spectrum (e.g., profound or severe
intellectual deficiencies) are incapable of independent function and require a
highly structured environment with constant aid and supervision. At the other
end of the spectrum are those with unusually well-developed intellect (“gifted”).
Although this level of intellectual functioning offers many opportunities, it can
also be associated with functional challenges related to socialization and learning
and communication style. Individuals whose intellect falls in the below-average
range (sometimes referred to as the “borderline” or “slow learner” range) tend to
experience greater difficulty processing and managing information that is
abstract, making connections between concepts and ideas, and generalizing
information (e.g., may be able to comprehend a concept in one setting but are
unable to carry it over and apply it in different situation). In general, these
individuals tend to do better when information is presented in more concrete and
explicit terms, and when working with rote information (e.g., memorizing
specific material). Stronger intellect has been associated with better-developed
concept formation, critical thinking, problem solving, understanding and
formulation of rules, brainstorming and creativity, and metacognition (ability to
“think about thinking”).
Memory
Memory is a term used to describe the cognitive mechanism by which
information is acquired, retained, and recalled. Structurally, some major brain
areas involved in memory processing include the hippocampus, fornix, temporal
lobes, and cerebellum, with connections in and between most brain regions. The
memory system can be partitioned into subsystems based on processing
sequences; the form, time span, and method of recall; whether memories are
conscious or unconsciously recalled; and the types of memory impairments that
can occur.
Once information has been identified (through auditory, visual, tactile, and/or
other sensory processes), it needs to be encoded and registered , a mental
process that constructs a representation of the information into the memory
system. The period (typically seconds) during which this information is being
held and/or manipulated for registration, and ultimately encoded, consolidated,
and retained, is referred to as working memory . Other descriptors include
short-term memory and immediate memory . Consolidation and storage
represent the process by which information in short-term memory is transferred
into long-term memory . Information in long-term memory can be available for
hours or as long as a life span. Long-term memories are generally thought to be
housed, in whole or in part, in specific brain regions (e.g., cortex, cerebellum).
Ordinarily, consolidation in long-term memory is accomplished in 1 or more of 4
ways: pairing 2 bits of information (e.g., a group of letters and the English sound
it represents); storing procedures (consolidating new skills, e.g., the steps in
solving mathematics problems); classifying data in categories (filing all insects
together in memory); and linking new information to established rules, patterns,
or systems of organization (rule-based learning).
Once information finds its way into long-term memory, it must be accessed. In
general, information can be retrieved spontaneously (a process known as free
recall ) or with the aid of cues (cued or recognition recall ). Some other
common descriptors of memory include anterograde memory (capacity to learn
from a single point in time forward), retrograde memory (capacity to recall
information that was already learned), and explicit memory (conscious
awareness of recall), implicit memory (subconscious recall: no awareness that
the memory system is being activated), procedural memory (memory for how
to do things), and prospective memory or remembering to remember .
Automatization reflects the ability to instantaneously access what has been
learned in the past with no expenditure of effort. Successful students are able to
automatically form letters, master mathematical facts, and decode words.
Social Cognition
The development of effective social skills is heavily dependent on secure social
cognition, which consists of mental processes that allow an individual to
understand and interact with the social environment. Although some evidence
shows that social cognition exists as a discrete area of neurodevelopmental
function, multiple cognitive processes are involved with social cognition. These
include the ability to recognize, interpret, and make sense of the thoughts,
communications (verbal and nonverbal), and actions of others; the ability to
understand that others' perceptions, perspectives, and intentions might differ
from one's own (commonly referred to as “theory of mind”); the ability to use
language to communicate with others socially (pragmatic language); and the
ability to make inferences about others and the environment based on contextual
information. It can also be argued that social cognition involves processes
associated with memory and EFs such as flexibility.
Executive Function
The development of EFs begins very early on in the developmental course (early
indications of inhibitory control and even working memory have been found in
infancy), matures significantly during the preschool years, and continues to
develop through adolescence and well into adulthood. Some studies suggest that
secure EF may be more important than intellectual ability for academic success
and have revealed that a child's ability to delay gratification early in life predicts
competency, attention, self-regulation, frustration tolerance, aptitude, physical
and mental health, and even substance dependency in adolescence and
adulthood. Conversely, deficits in other areas of neurodevelopment, such as
language development, impact EF.
Attention is far from a unitary, independent, or specific brain function. This
may be best illustrated through the phenotype associated with ADHD) (see
Chapter 49 ). Disordered attention can result from faulty mechanisms in and
across subdomains of attention. These subdomains include selective attention
(ability to focus attention on a particular stimulus and to discriminate relevant
from irrelevant information), divided attention (ability to orient to more than one
stimulus at a given time), sustained attention (ability to maintain one's focus),
and alternating attention (capacity to shift focus between stimuli).
Attention problems in children can manifest at any point, from arousal
through output. Children with diminished alertness and arousal can exhibit signs
of mental fatigue in a classroom or when engaged in any activity requiring
sustained focus. They are apt to have difficulty allocating and sustaining their
concentration, and their efforts may be erratic and unpredictable, with extreme
performance inconsistency. Weaknesses of determining saliency often result in
focusing on the wrong stimuli, at home, in school, and socially, and missing
important information. Distractibility can take the form of listening to
extraneous noises instead of a teacher, staring out the window, or constantly
thinking about the future. Attention dysfunction can affect the output of work,
behavior, and social activity. It is important to appreciate that most children with
attentional dysfunction also harbor other forms of neurodevelopmental
dysfunction that can be associated with academic disorders (with some estimates
suggesting up to 60% comorbidity).
Inhibitory control (IC) can be described as one's ability to restrain, resist,
and not act (cognitively or behaviorally/emotionally) on a thought. IC may also
be seen as one's ability to stop thoughts or ongoing actions. Deficits in this
behavioral/impulse regulation mechanism are a core feature of the combined or
hyperactive impulsive presentation of ADHD and have a significant adverse
impact on a child's overall functioning. In everyday settings, children with weak
IC may exhibit difficulties with self-control and self-monitoring of their
behavior and output (e.g., impulsivity), may not recognize their own errors or
mistakes, and often act prematurely and without consideration of the potential
consequences of their actions. In the social context, disinhibited children may
interrupt others and demonstrate other impulsive behaviors that often interfere
with interpersonal relationships. The indirect consequences of poor IC often lead
to challenges with behavior, emotional, and academic functioning and social
interaction (Table 48.1 ).
Table 48.1
Clinical Manifestations
The symptoms and clinical manifestations of neurodevelopmental and executive
dysfunction differ with age. Preschool-age children might present with delayed
language development, including problems with articulation, vocabulary
development, word finding, and rhyming. They often experience early
challenges with learning colors, shapes, letters, and numbers; the alphabet; and
days of the week. Children with visual processing deficits may have difficulty
learning to draw and write and have problems with art activities. These children
might also have trouble discriminating between left and right. They might
encounter problems recognizing letters and words. Difficulty following
instructions, overactivity, and distractibility may be early symptoms of emerging
executive dysfunction. Difficulties with fine motor development (e.g., grasping
crayons/pencils, coloring, drawing) and social interaction may develop.
School-age children with neurodevelopmental and executive dysfunctions
can vary widely in clinical presentations. Their specific patterns of academic
performance and behavior represent final common pathways of
neurodevelopmental strengths and deficits interacting with environmental,
social, or cultural factors; temperament; educational experience; and intrinsic
resilience (Table 48.2 ). Children with language weaknesses might have
problems integrating and associating letters and sounds, decoding words,
deriving meaning, and being able to comprehend passages. Children with early
signs of a mathematics weakness might have difficulty with concepts of quantity
or with adding or subtracting without using concrete representation (e.g., their
fingers when calculating). Difficulty learning time concepts and confusion with
directions (right/left) might also be observed. Poor fine motor control and
coordination and poor planning can lead to writing problems. Attention and
behavioral regulation weaknesses observed earlier can continue, and together
with other executive functioning weaknesses (e.g., organization, initiation skills),
further complicate the child's ability to acquire and generalize new knowledge.
Children with weaknesses in WM may struggle to remember the steps necessary
to complete an activity or problem-solve. In social settings, these children often
have difficulty keeping up with more complex conversations.
Table 48.2
Academic Problems
Reading disorders (see Chapter 50 ) can stem from any number of
neurodevelopmental dysfunctions, as described earlier (see Table 48.2 ). Most
often, language and auditory processing weaknesses are present, as evidenced by
poor phonologic processing that results in deficiencies at the level of decoding
individual words and, consequently, a delay in automaticity (e.g., acquiring a
repertoire of words readers can identify instantly) that causes reading to be slow,
laborious, and frustrating. Deficits in other core neurodevelopmental domains
might also be present. Weak WM might make it difficult for a child to hold
sounds and symbols in mind while breaking down words into their component
sounds, or might cause reading comprehension problems. Some children
experience temporal-ordering weaknesses and struggle with reblending
phonemes into correct sequences. Memory dysfunction can cause problems with
recall and summarization of what was read. Some children with higher-order
cognitive deficiencies have trouble understanding what they read because they
lack a strong grasp of the concepts in a text. Although relatively rare as a cause
of reading difficulty, problems with visual-spatial functions (e.g., visual
perception) can cause children difficulty in recognizing letters. It is not unusual
for children with reading problems to avoid reading practice, and a delay in
reading proficiency becomes increasingly pronounced and difficult to remediate.
Spelling and writing impairments share many related underlying processing
deficits with reading, so it is not surprising that the 2 disorders often occur
simultaneously in school-age children (see Table 48.2 ). Core
neurodevelopmental weaknesses that underlie spelling difficulties include
phonologic and decoding difficulties, orthographic problems (coding letters and
words into memory), and morphologic deficits (use of suffixes, prefixes, and
root words). Problems in these areas can manifest as phonetically poor, yet
visually comparable approximations to the actual word (faght for fight ), spelling
that is phonetically correct but visually incorrect (fite for fight ), and inadequate
spelling patterns (played as plade). Children with memory disorders might
misspell words because of coding weaknesses. Others misspell because of poor
auditory WM that interferes with their ability to process letters. Sequencing
weaknesses often result in transposition errors when spelling.
Writing difficulties have been classified as disorder of written expression , or
dysgraphia (see Table 48.2 ). Although many of the same dysfunctions
described for reading and spelling can contribute to problems with writing,
written expression is the most complex of the language arts, requiring synthesis
of many neurodevelopmental functions (e.g., auditory, visual-spatial, memory,
executive; see Chapter 51.2 ). Weaknesses in these functions can result in written
output that is difficult to comprehend, disjointed, and poorly organized. The
child with WM challenges can lose track of what the child intended to write.
Attention deficits can make it difficult for a child to mobilize and sustain the
mental effort, pacing, and self-monitoring demands necessary for writing. In
many cases, writing is laborious because of an underlying graphomotor
dysfunction (e.g., fluency does not keep pace with ideation and language
production). Thoughts may also be forgotten or underdeveloped during writing
because the mechanical effort is so taxing.
Weaknesses in mathematical ability, known as mathematics disorder or
dyscalculia , require early intervention because math involves the assimilation
of both procedural knowledge (e.g., calculations) and higher-order cognitive
processes (e.g., WM) (see Table 48.2 ). There are many reasons why children
experience failure in mathematics (see Chapter 51.1 ). It may be difficult for
some to grasp and apply math concepts effectively and systematically; good
mathematicians are able to use both verbal and perceptual conceptualization to
understand such concepts as fractions, percentages, equations, and proportion.
Children with language dysfunctions have difficulty in mathematics because
they have trouble understanding their teachers' verbal explanations of
quantitative concepts and operations and are likely to experience frustration in
solving word problems and in processing the vast network of technical
vocabulary in math. Mathematics also relies on visualization. Children who have
difficulty forming and recalling visual imagery may be at a disadvantage in
acquiring mathematical skills. They might experience problems writing numbers
correctly, placing value locations, and processing geometric shapes or fractions.
Children with executive dysfunction may be unable to focus on fine detail (e.g.,
operational signs), might take an impulsive approach to problem solving, engage
in little or no self-monitoring, forget components of the problem, or commit
careless errors. When a child's memory system is weak, the child might have
difficulty recalling appropriate procedures and automatizing mathematical facts
(e.g., multiplication tables). Moreover, children with mathematical disabilities
can have superimposed mathematics phobias ; anxiety over mathematics can be
especially debilitating.
Nonacademic Problems
The impulsivity and lack of effective self-monitoring of children with executive
dysfunction can lead to unacceptable actions that were unintentional. Children
struggling with neurodevelopmental dysfunction can experience excessive
performance anxiety, sadness, or clinical depression; declining self-esteem; and
chronic fatigue. Some children lose motivation. They tend to give up and exhibit
learned helplessness, a sense that they have no control over their destiny.
Therefore they feel no need to exert effort and develop future goals. These
children may be easily led toward dysfunctional interpersonal relationships,
detrimental behaviors (e.g., delinquency), and the development of mental health
disorders, such as mood disorders (see Chapter 39 ) or conduct disorder (Chapter
42 ).
Treatment
In addition to addressing any underlying or associated medical problems, the
pediatrician can play an important role as a consultant and advocate in
overseeing and monitoring the implementation of a comprehensive
multidisciplinary management plan for children with neurodevelopmental
dysfunctions. Most children require several of the following forms of
intervention.
Demystification
Many children with neurodevelopmental dysfunctions have little or no
understanding of the nature or sources of their academic difficulties. Once an
appropriate descriptive assessment has been performed, it is important to explain
to the child the nature of the dysfunction while delineating the child's strengths.
This explanation should be provided in nontechnical language, communicating a
sense of optimism and a desire to be helpful and supportive.
Table 48.3
Developmental Therapy
Speech-language pathologists offer intervention for children with various forms
of language disability. Occupational therapists focus on sensorimotor skills,
including the motor skills of students with writing problems, and physical
therapists address gross motor incoordination.
Curriculum Modifications
Many children with neurodevelopmental dysfunctions require alterations in the
school curriculum to succeed, especially as they progress through secondary
school. Students with memory weaknesses might need to have their courses
selected for them so that they do not have an inordinate cumulative memory load
in any single semester. The timing of foreign language learning, the selection of
a mathematics curriculum, and the choice of science courses are critical issues
for many of these struggling adolescents.
Strengthening of Strengths
Affected children need to have their affinities, potentials, and talents identified
clearly and exploited widely. It is as important to augment strengths as it is to
attempt to remedy deficiencies. Athletic skills, artistic inclinations, creative
talents, and mechanical abilities are among the potential assets of certain
students who are underachieving academically. Parents and school personnel
need to create opportunities for such students to build on these assets and to
achieve respect and praise for their efforts. These well-developed personal assets
can ultimately have implications for the transition into young adulthood,
including career or college selection.
Nonstandard Therapies
A variety of treatment methods for neurodevelopmental dysfunctions have been
proposed that currently have little to no known scientific evidence of efficacy.
This list includes dietary interventions (vitamins, elimination of food additives
or potential allergens), neuromotor programs or medications to address
vestibular dysfunction, eye exercises, filters, tinted lenses, and various
technologic devices. Parents should be cautioned against expending the
excessive amounts of time and financial resources usually demanded by these
remedies. In many cases, it is difficult to distinguish the nonspecific beneficial
effects of increased support and attention paid to the child from the supposed
target effects of the intervention.
Medication
Psychopharmacologic agents may be helpful in lessening the toll of some
neurodevelopmental dysfunctions. Most often, stimulants are used in the
treatment of children with attention deficits. Although most children with
attention deficits have other associated dysfunctions, such as language disorders,
memory problems, motor weaknesses, or social skill deficits, medications such
as methylphenidate, dextroamphetamine, lisdexamfetamine, and mixed
amphetamine salts, as well as nonstimulants such as α2 -adrenergic agonists
and atomoxetine , can be important adjuncts to treatment by helping some
children focus more selectively and control their impulsivity. When depression
or excessive anxiety is a significant component of the clinical picture,
antidepressants or anxiolytics may be helpful. Other drugs may improve
behavioral control (see Chapter 33 ). Children receiving medication need regular
follow-up visits that include a history to check for side effects, a review of
current behavioral checklists, a complete physical examination, and appropriate
modifications of the medication dose. Periodic trials off medication are
recommended to establish whether the medication is still necessary.
Bibliography
American Academy of Pediatrics, Committee on Children with
Disabilities. The pediatrician's role in development and
implementation of an Individual Education Plan (IEP) and/or
an Individual Family Service Plan (IFSP). Pediatrics .
1999;104:124–127.
Anderson PJ, Reidy N. Assessing executive function in
preschoolers. Neuropsychol Rev . 2012;22:345–360.
Cuevas K, Bell MA. Infant attention and early childhood
executive function. Child Dev . 2014;85(2):397–404.
Eicher JD, Montgomery AM, Akshoomoff N, et al. Dyslexia
and language impairment associated genetic markers
influence cortical thickness and white matter in typically
developing children. Brain Imaging Behav . 2016;10:272–
282.
Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating
inventory of executive function . ed 2. Psychological
Assessment Resources: Lutz, FL; 2015 [(BRIEF2);
Professional manual].
Griffin JA, McCardle P, Freund LS. Executive function in
preschool-age children, integrating measurement,
neurodevelopment, and translational research . American
Psychological Association: Washington, DC; 2016.
Ransom DM, Vaughan CG, Pratson L. Academic effects of
concussion in children and adolescents. Pediatrics .
2015;135(6).
Swillen A, McDonald-McGinn DM. Developmental trajectories
in 22q11.2 deletion. Am J Med Genet C Semin Med Genet .
2015;169(2):172–181.
Zelazo PD, Carlson SM. Hot and cool executive function in
childhood and adolescence: development and plasticity. Child
Dev Perspect . 2012;6(4):354–360.
CHAPTER 49
Attention-Deficit/Hyperactivity
Disorder
David K. Urion
Table 49.2
Differences Between U.S. and European Criteria for ADHD
or HKD
Table 49.3
Differential Diagnosis of Attention-
Deficit/Hyperactivity Disorder (ADHD)
Psychosocial Factors
Fragile X syndrome
Fetal alcohol syndrome
Pervasive developmental disorders
Obsessive-compulsive disorder
Gilles de la Tourette syndrome
Attachment disorder with mixed emotions and conduct
Etiology
No single factor determines the expression of ADHD; ADHD may be a final
common pathway for a variety of complex brain developmental processes.
Mothers of children with ADHD are more likely to experience birth
complications, such as toxemia, lengthy labor, and complicated delivery.
Maternal drug use has also been identified as a risk factor in the development of
ADHD. Maternal smoking, alcohol use during pregnancy, and prenatal or
postnatal exposure to lead are frequently linked to the attentional difficulties
associated with development of ADHD, but less clearly to hyperactivity. Food
coloring and preservatives have inconsistently been associated with increased
hyperactivity in children with ADHD.
There is a strong genetic component to ADHD. Genetic studies have primarily
implicated 2 candidate genes, the dopamine transporter gene (DAT1) and a
particular form of the dopamine 4 receptor gene (DRD4), in the development of
ADHD. Additional genes that might contribute to ADHD include DOCK2,
associated with a pericentric inversion 46N inv(3)(p14:q21) involved in cytokine
regulation; a sodium-hydrogen exchange gene; and DRD5, SLC6A3, DBH,
SNAP25, SLC6A4, and HTR1B.
Structural and functional abnormalities of the brain have been identified in
children with ADHD. These include dysregulation of the frontal subcortical
circuits, small cortical volumes in this region, widespread small-volume
reduction throughout the brain, and abnormalities of the cerebellum, particularly
midline/vermian elements (see Pathogenesis ). Brain injury also increases the
risk of ADHD. For example, 20% of children with severe traumatic brain injury
are reported to have subsequent onset of substantial symptoms of impulsivity
and inattention. However, ADHD may also increase the risk of traumatic brain
injury.
Psychosocial family stressors can also contribute to or exacerbate the
symptoms of ADHD, including poverty, exposure to violence, and
undernutrition or malnutrition.
Epidemiology
Studies of the prevalence of ADHD worldwide have generally reported that 5–
10% of school-age children are affected, although rates vary considerably by
country, perhaps in part because of differing sampling and testing techniques.
Rates may be higher if symptoms (inattention, impulsivity, hyperactivity) are
considered in the absence of functional impairment. The prevalence rate in
adolescent samples is 2–6%. Approximately 2% of adults meet criteria for
ADHD. ADHD is often underdiagnosed in children and adolescents. Youth with
ADHD are often undertreated with respect to what is known about the needed
and appropriate doses of medications. Many children with ADHD also present
with comorbid neuropsychiatric diagnoses, including oppositional defiant
disorder, conduct disorder, learning disabilities, and anxiety disorders. The
incidence of ADHD appears increased in children with neurologic disorders such
as the epilepsies, neurofibromatosis, and tuberous sclerosis (see Table 49.3 ).
Pathogenesis
Brain MRI studies in children with ADHD indicate a reduction or even loss of
the normal hemispheric asymmetry in the brain, as well as smaller brain volumes
of specific structures, such as the prefrontal cortex and basal ganglia. Children
with ADHD have approximately a 5–10% reduction in the volume of these brain
structures. MRI findings suggest low blood flow to the striatum. Functional MRI
data suggest deficits in dispersed functional networks for selective and sustained
attention in ADHD that include the striatum, prefrontal regions, parietal lobe,
and temporal lobe. The prefrontal cortex and basal ganglia are rich in dopamine
receptors. This knowledge, plus data about the dopaminergic mechanisms of
action of medication treatment for ADHD, has led to the dopamine hypothesis,
which postulates that disturbances in the dopamine system may be related to the
onset of ADHD. Fluorodopa positron emission tomography (PET) scans also
support the dopamine hypothesis through the identification of low levels of
dopamine activity in adults with ADHD.
Clinical Manifestations
Development of the Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-5) criteria leading to the diagnosis of ADHD has occurred
mainly in field trials with children 5-12 yr of age (see Table 49.1 and Fig. 49.1 ).
The DSM-5 notably expanded the accepted age of onset for symptoms of
ADHD, and studies utilizing these broader criteria demonstrate a good
correlation with data from DSM-IV criteria–based studies. The current DSM-5
criteria state that the behavior must be developmentally inappropriate
(substantially different from that of other children of the same age and
developmental level), must begin before age 12 yr, must be present for at least 6
mo, must be present in 2 or more settings and reported as such by independent
observers, and must not be secondary to another disorder. DSM-5 identifies three
presentations of ADHD. The inattentive presentation is more common in
females and is associated with relatively high rates of internalizing symptoms
(anxiety and low mood). The other two presentations, hyperactive-impulsive
and combined , are more often diagnosed in males (see Fig. 49.1 ).
Clinical manifestations of ADHD may change with age (see Fig. 49.2 ). The
symptoms may vary from motor restlessness and aggressive and disruptive
behavior, which are common in preschool children, to disorganized, distractible,
and inattentive symptoms, which are more typical in older adolescents and
adults. ADHD is often difficult to diagnose in preschoolers because
distractibility and inattention are often considered developmental norms during
this period.
Differential Diagnosis
Chronic illnesses, such as migraine headaches, absence seizures,
asthma/allergies, hematologic disorders, diabetes, and childhood cancer, affect
up to 20% of U.S. children and can impair children's attention and school
performance, because of either the disease itself or the medications used to treat
or control the underlying illness (medications for asthma, corticosteroids,
anticonvulsants, antihistamines) (see Table 49.3 ). In older children and
adolescents, substance abuse can result in declining school performance and
inattentive behavior (see Chapter 140 ).
Sleep disorders , including those secondary to chronic upper airway
obstruction from enlarged tonsils and adenoids, often result in behavioral and
emotional symptoms that can resemble or exacerbate ADHD (see Chapter 31 ).
Periodic leg movements of sleep/restless leg syndrome has been associated with
attentional symptoms, and inquiry regarding this should be made during the
history. Behavioral and emotional disorders can cause disrupted sleep patterns as
well.
Depression and anxiety disorders can cause many of the same symptoms as
ADHD (inattention, restlessness, inability to focus and concentrate on work,
poor organization, forgetfulness) but can also be comorbid conditions (see
Chapters 38 and 39 ). Obsessive-compulsive disorder can mimic ADHD,
particularly when recurrent and persistent thoughts, impulses, or images are
intrusive and interfere with normal daily activities. Adjustment disorders
secondary to major life stresses (death of a close family member, parents'
divorce, family violence, parents' substance abuse, a move, shared social trauma
such as bombings or other attacks) or parent–child relationship disorders
involving conflicts over discipline, overt child abuse and/or neglect, or
overprotection can result in symptoms similar to those of ADHD.
Although ADHD is believed to result from primary impairment of attention,
impulse control, and motor activity, there is a high prevalence of comorbidity
with other neuropsychiatric disorders (see Table 49.3 ). Of children with ADHD,
15–25% have learning disabilities, 30–35% have developmental language
disorders, 15–20% have diagnosed mood disorders, and 20–25% have coexisting
anxiety disorders. Children with ADHD can also have concurrent diagnoses of
sleep disorders, memory impairment, and decreased motor skills.
Treatment
Psychosocial Treatments
Once the diagnosis of ADHD has been established, the parents and child should
be educated with regard to the ways ADHD can affect learning, behavior, self-
esteem, social skills, and family function. The clinician should set goals for the
family to improve the child's interpersonal relationships, develop study skills,
and decrease disruptive behaviors. Parent support groups with appropriate
professional consultation to such groups can be very helpful.
Medications
The most widely used medications for the treatment of ADHD are the
presynaptic dopaminergic agonists, commonly called psychostimulant
medications, including methylphenidate, dexmethylphenidate, amphetamine, and
various amphetamine and dextroamphetamine preparations. Longer-acting,
once-daily forms of each of the major types of stimulant medications are
available and facilitate compliance with treatment and coverage over a longer
period (see Table 49.3 ). When starting a stimulant, the clinician can select either
a methylphenidate-based or an amphetamine-based compound. If a full range of
methylphenidate dosages is used, approximately 25% of patients have an
optimal response on a low dose (<0.5 mg/kg/day for methylphenidate, <0.25
mg/kg/day for amphetamines), 25% on a medium dose (0.5-1.0 mg/kg/day for
methylphenidate, 0.25-0.5 mg/kg/day for amphetamines), and 25% on a high
dose (1.0-1.5 mg/day for methylphenidate, 0.5-0.75 mg/kg/day for
amphetamine); another 25% will be unresponsive or will have side effects,
making that drug particularly unpalatable for the family (See Table 33.2 for more
information on dosing).
Over the first 4 wk of treatment, the physician should increase the medication
dose as tolerated (keeping side effects minimal to absent) to achieve maximum
benefit. If this strategy does not yield satisfactory results, or if side effects
prevent further dose adjustment in the presence of persisting symptoms, the
clinician should use an alternative class of stimulants that was not used
previously. If a methylphenidate compound is unsuccessful, the clinician should
switch to an amphetamine product. If satisfactory treatment results are not
obtained with the 2nd stimulant, clinicians may choose to prescribe atomoxetine,
a noradrenergic reuptake inhibitor that has been approved by the U.S. Food and
Drug Administration (FDA) for the treatment of ADHD in children, adolescents,
and adults. Atomoxetine should be initiated at a dose of 0.3 mg/kg/day and
titrated over 1-3 wk to a maximum total daily dosage of 1.2-1.4 mg/kg/day. The
dose should be divided into twice-daily portions. Once-daily dosing appears to
be associated with a high incidence of treatment failure. Long-acting guanfacine
and clonidine are also FDA approved for the treatment of ADHD (see Chapter
33 ). These medications can also treat motor and vocal tics and so may be a
reasonable choice in a child with a comorbid tic disorder. Drugs to treat ADHD
do not increase the incidence of tics in children predisposed to a tic disorder. In
the past, tricyclic antidepressants have been used to treat ADHD, but TCAs are
rarely used now because of the risk of sudden death, particularly if an overdose
is taken.
The clinician should consider careful monitoring of medication a necessary
component of treatment in children with ADHD. When physicians prescribe
medications for the treatment of ADHD, they tend to use lower-than-optimal
doses. Optimal treatment usually requires somewhat higher doses than tend to be
found in routine practice settings. All-day preparations are also useful to
maximize positive effects and minimize side effects, and regular medication
follow-up visits should be offered (≥4 times/yr) as opposed to the twice-yearly
medication visits often used in standard community care settings.
Medication alone may not be sufficient to treat ADHD in children,
particularly when children have multiple psychiatric disorders or a stressed home
environment. When children do not respond to medication, it may be appropriate
to refer them to a mental health specialist. Consultation with a child psychiatrist,
developmental-behavioral pediatrician, or psychologist can also be beneficial to
determine the next steps for treatment, including adding other components and
supports to the overall treatment program. Evidence suggests that children who
receive careful medication management, accompanied by frequent treatment
follow-up, all within the context of an educative, supportive relationship with the
primary care provider, are likely to experience behavioral gains.
Stimulant drugs used to treat ADHD may be associated with an increased risk
of adverse cardiovascular events, including sudden cardiac death, myocardial
infarction, and stroke, in young adults and rarely in children. In some of the
reported cases, the patient had an underlying disorder, such as hypertrophic
obstructive cardiomyopathy, which is made worse by sympathomimetic agents.
These events are rare but nonetheless warrant consideration before initiating
treatment and during monitoring of therapy with stimulants. Children with a
positive personal or family history of cardiomyopathy, arrhythmias, or syncope
require an electrocardiogram and possible cardiology consultation before a
stimulant is prescribed (Fig. 49.4 ).
Prognosis
A childhood diagnosis of ADHD often leads to persistent ADHD throughout the
life span. From 60–80% of children with ADHD continue to experience
symptoms in adolescence, and up to 40–60% of adolescents exhibit ADHD
symptoms into adulthood. In children with ADHD, a reduction in hyperactive
behavior often occurs with age. Other symptoms associated with ADHD can
become more prominent with age, such as inattention, impulsivity, and
disorganization, and these exact a heavy toll on young adult functioning. Risk
factors in children with untreated ADHD as they become adults include
engaging in risk-taking behaviors (sexual activity, delinquent behaviors,
substance use), educational underachievement or employment difficulties, and
relationship difficulties. With proper treatment, the risks associated with ADHD,
including injuries, can be significantly reduced. Consistent treatment with
medication and adjuvant therapies appears to lower the risk of adverse outcomes,
such as substance abuse.
Prevention
Parent training can lead to significant improvements in preschool children with
ADHD symptoms, and parent training for preschool youth with ADHD can
reduce oppositional behavior. To the extent that parents, teachers, physicians,
and policymakers support efforts for earlier detection, diagnosis, and treatment,
prevention of long-term adverse effects of ADHD on affected children's lives
should be reconsidered within the lens of prevention. Given the effective
treatments for ADHD now available, and the well-documented evidence about
the long-term effects of untreated or ineffectively treated ADHD on children and
youth, prevention of these consequences should be within the grasp of
physicians and the children and families with ADHD for whom we are
responsible.
Bibliography
American Academy of Pediatrics/American Heart Association.
AAP/AHA clarification of statement on cardiovascular
evaluation and monitoring of children and adolescents with
heart disease receiving medications for ADHD: 2008. J Dev
Behav Pediatr . 2008;29(4):335.
Atkinson M, Hollis C. NICE guideline: attention deficit
hyperactivity disorder. Arch Dis Child Educ Pract Ed .
2010;95:24–27.
Babcock T, Ornstein CS. Comorbidity and its impact in adult
patients with attention-deficit/hyperactivity disorder: a
primary care perspective. Postgrad Med . 2009;121:73–82.
Barbaresi W, et al. Mortality, ADHD, and psychosocial
adversity in adults with childhood ADHD: a prospective
study. Pediatrics . 2013;131(4):637–644.
Barkley RA, Fischer M, Smallish L, et al. Young adult outcome
of hyperactive children: adaptive functioning in major life
activities. J Am Acad Child Adolesc Psychiatry .
2006;45:192–202.
Bouchard MF, Bellinger DC, Wright RO, et al. Attention-deficit
hyperactivity disorder and urinary metabolites of
organophosphate pesticides. Pediatrics . 2010;125:e1270–
e1277.
Brookes KJ, Mill J, Guindalini C, et al. A common haplotype of
the dopamine transporter gene associated with attention-
deficit/hyperactivity disorder and interacting with maternal
use of alcohol during pregnancy. Arch Gen Psychiatry .
2006;63:74–81.
Caspi A, Langley K, Milne B, et al. A replicated molecular
genetic basis for subtyping antisocial behavior in children
with attention-deficit/ hyperactivity disorder. Arch Gen
Psychiatry . 2008;65:203–210.
Centers for Disease Control and Prevention. Percentage of
children and teens aged 4-17 years ever diagnosed with
attention-deficit/hyperactivity disorder (ADHD) by sex and
urbanization of county residence—National Health Interview
Survey, 2013–2015. MMWR Morb Mortal Wkly Rep .
2016;66(23):625.
Chan E, Fogler JA, Hammerness PG. Treatment of attention-
deficit/hyperactivity disorder in adolescents: a systematic
review. JAMA . 2016;315(18):1997–2008.
Chang Z, Quinn PD, Hur K, et al. Association between
medication use for attention-deficit/hyperactivity disorder and
risk of motor vehicle crashes. JAMA Psychiatry .
2017;74(6):597–603.
Cohen SC, Mulqueen JM, Ferracioli-Oda E, et al. Meta-
analysis: risk of tics associated with psychostimulant use in
randomized, placebo-controlled trials. J Am Acad Child
Adolesc Psychiatry . 2015;54(9):728–736.
Dalsgaard S, Leckman JF, Mortensen PB, et al. Effect of drugs
on the risk of injuries in children with attention deficit
hyperactivity disorder: a prospective cohort study. Lancet
Psychiatry . 2015;2:702–709.
Eigenmann PA, Haenggeli CA. Food colourings, preservatives,
and hyperactivity. Lancet . 2007;370:1524–1525.
Faraone SV. Attention deficit hyperactivity disorder and
premature death. Lancet . 2015;385:2132–2133.
Franke AG, Gransmark P, Agricola A, et al. Methylphenidate,
modafinil, and caffeine for cognitive enhancement in chess: a
double-blind, randomized controlled trial. Eur
Neuropsychopharmacol . 2017;27:248–260.
Friedland S, Walkup JT. Meta-assurance: no tic exacerbation
caused by stimulants. J Am Acad Child Adolesc Psychiatry .
2015;54(9):706–708.
Gloss D, Varma JK, Pringsheim T, Nuwer MR. Practice
advisory: the utility of EEG theta/beta power ratio in ADHD
diagnosis. Neurology . 2016;97:1–5.
Gould MS, Walsh BT, Munfakh JL, et al. Sudden death and use
of stimulant medications in youths. Am J Psychiatry .
2009;166:992–1101.
Greenhill L, Kollins S, Abikoff H, et al. Efficacy and safety of
immediate-release methylphenidate treatment for
preschoolers with ADHD. J Am Acad Child Adolesc
Psychiatry . 2006;45:1284–1293.
Hammerness P, Wilens T, Mick E, et al. Cardiovascular effects
of longer-term, high-dose OROS methylphenidate in
adolescents with attention deficit hyperactivity disorder. J
Pediatr . 2009;155:84–89.
Harpin VA. Medication options when treating children and
adolescents with ADHA: interpreting the NICE guidance
2006. Arch Dis Child Educ Pract Ed . 2008;93:58–66.
Hartanto TA, Krafft CE, Iosif AM, Schweitzer JB. A trial-by-
trial analysis reveals more intense physical activity is
associated with better cognitive control performance in
attention-deficit/hyperactivity disorder. Child Neuropsychol .
2016;22(5):618–626.
Jones K, Daley D, Hutchings J, et al. Efficacy of the Incredible
Years Programme as an early intervention for children with
conduct problems and ADHD: long-term follow-up. Child
Care Health Dev . 2008;34:380–390.
Kendall T, Taylor E, Perez A, et al. Diagnosis and management
of attention-deficit/hyperactivity disorder in children, young
people, and adults: summary of NICE guidance. BMJ .
2008;337:751–754.
Knight M. Stimulant-drug therapy for attention-deficit disorder
(with or without hyperactivity) and sudden cardiac death.
Pediatrics . 2007;119:154–155.
Kollins S, Greenhill L, Swanson J, et al. Rationale, design, and
methods of the Preschool ADHA Treatment Study (PATS). J
Am Acad Child Adolesc Psychiatry . 2006;45:1275–1283.
Langberg JM, Brinkman WB, Lichtenstein PK, et al.
Interventions to promote the evidence-based care of children
with ADHD in primary-care settings. Expert Rev Neurother .
2009;9:477–487.
Man KKC, Chan EW, Ip P, et al. Prenatal antidepressant use and
risk of attention-deficit/hyperactivity disorder in offspring:
population based cohort study. BMJ . 2017;357:j2350.
McCann D, Barrett A, Cooper A, et al. Food additives and
hyperactive behaviour in 3-year-old and 8/9-year-old children
in the community: a randomized, double-blind, placebo-
controlled trial. Lancet . 2007;370:1560–1567.
2010. The Medical Letter: Guanfacine extended-release (Intuniv) for
ADHD. Med Lett Drugs Ther . 2010;52:82.
2015. The Medical Letter: Drugs for ADHD. Med Lett Drugs Ther .
2015;57:37–40.
2016. The Medical Letter: Two new amphetamines for ADHD. Med
Lett Drugs Ther . 2016;58(1497):80–81.
Mosholder AD, Gelperin K, Hammad TA, et al. Hallucinations
and other psychotic symptoms associated with the use of
attention-deficit/hyperactivity disorder drugs in children.
Pediatrics . 2009;123:611–616.
Newcorn JH. Managing ADHD and comorbidities in adults. J
Clin Psychiatry . 2009;70(2):e40.
Newcorn JH, Kratochvil CJ, Allen AJ, et al. Atomoxetine and
osmotically released methylphenidate for the treatment of
attention deficit hyperactivity disorder: acute comparison and
differential response. Am J Psychiatry . 2008;165:721–730.
Newcorn JH, Sutton VK, Weiss MD, et al. Clinical responses to
atomoxetine in attention-deficit/hyperactivity disorder: the
integrated Data Exploratory Analysis (IDEA) study. J Am
Acad Child Adolesc Psychiatry . 2009;48:511–518.
Nutt DJ, Fone K, Asherson P, et al. Evidence-based guidelines
for management of attention-deficit/hyperactivity disorder in
adolescents in transition to adult services and in adults:
recommendations from the British Association for
Psychopharmacology. J Psychopharmacol . 2007;21:10–41.
Okie S. ADHD in adults. N Engl J Med . 2006;354:2637–2641.
Pelsser LM, Frankena K, Toorman J, et al. Effects of restricted
elimination diet on the behaviour of children with attention-
deficit hyperactivity disorder (INCA study): a randomised
controlled trial. Lancet . 2011;377:494–503.
Perrin JM, Friedman RA, Knilans TK. Cardiovascular
monitoring and stimulant drugs for attention-
deficit/hyperactivity disorder. Pediatrics . 2008;122:451–453.
Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral
therapy vs relaxation with educational support for medication
—adults with ADHD and persistent symptoms. JAMA .
2010;304:875–880.
Shaw P. Quantifying the benefits and risks of methylphenidate
as treatment for childhood attention-deficit/hyperactivity
disorder. JAMA . 2016;315(18):1953–1954.
Shin JY, Roughhead EE, Park BJ, Pratt NL. Cardiovascular
safety of methylphenidate among children and young people
with attention-deficit/hyperactivity disorder (ADHD):
nationwide self- controlled case series study. BMJ .
2016;353:i2550.
Shum SBM, Pang MYC. Children with attention deficit
hyperactivity disorder have impaired balance function:
involvement of somatosensory, visual, and vestibular
systems. J Pediatr . 2009;155:245–249.
Silk TJ, Vance A, Rinehart N, et al. Dysfunction in the fronto-
parietal network in attention deficit hyperactivity disorder
(ADHD): an fMRI study. Brain Imaging Behav .
1931;2:2008.
Smith AK, Mick E, Faraone SV. Advances in genetic studies of
attention-deficit/hyperactivity disorder. Curr Psychiatry Rep .
2009;11:143–148.
Sowell ER, Thompson PM, Welcome SE, et al. Cortical
abnormalities in children and adolescents with attention-
deficit disorder. Lancet . 2008;362:1699–1707.
Spencer TJ. ADHD and comorbidity in childhood. J Clin
Psychiatry . 2006;67(Suppl 8):27–31.
Thapar A, Cooper M. Attention deficit hyperactivity disorder.
Lancet . 2016;387:1240–1248.
Thomas PE, Carlo WE, Decker JA, et al. Impact of the
American Heart Association scientific statement on screening
electrocardiograms and stimulant medications. Arch Pediatr
Adolesc Med . 2011;165(2):166–170.
Verkuijl N, Perkins M, Fazel M. Childhood attention-
deficit/hyperactivity disorder. BMJ . 2015;350:h2168.
Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden
death: What is a physician to do? Pediatrics .
2006;118:1215–1219.
CHAPTER 50
Dyslexia
Sally E. Shaywitz, Bennett A. Shaywitz
The most current definition of dyslexia is now codified in U.S. Federal law (First
Step Act of 2018, PL: 115–391): “The term dyslexia means an unexpected
difficulty in reading for an individual who has the intelligence to be a much
better reader, most commonly caused by a difficulty in the phonological
processing (the appreciation of the individual sounds of spoken language), which
affects the ability of an individual to speak, read, and spell.” In typical readers,
development of reading and intelligence quotient (IQ) are dynamically linked
over time. In dyslexic readers, however, a developmental uncoupling occurs
between reading and IQ (Fig. 50.1 ), such that reading achievement is
significantly below what would be expected given the individual's IQ. The
discrepancy between reading achievement and IQ provides the long-sought
empirical evidence for the seeming paradox between cognition and reading in
individuals with developmental dyslexia, and this discrepancy is now recognized
in the Federal definition as unexpected difficulty in reading.
FIG. 50.1 Uncoupling of reading and IQ over time: empirical evidence for a definition
of dyslexia. Left , In typical readers, reading and IQ development are dynamically linked
over time. Right, In contrast, reading and IQ development are dissociated in dyslexic
readers, and one does not influence the other. (Data adapted from Ferrer E, Shaywitz
BA, Holahan JM, et al: Uncoupling of reading and IQ over time: empirical evidence for a
definition of dyslexia, Psychol Sci 21(1):93–101, 2010.)
Etiology
Dyslexia is familial, occurring in 50% of children who have a parent with
dyslexia, in 50% of the siblings of dyslexic persons, and in 50% of the parents of
dyslexic persons. Such observations have naturally led to a search for genes
responsible for dyslexia, and at one point there was hope that heritability would
be related to a small number of genes. Genome-wide association studies
(GWAS), however, have demonstrated that a large number of genes are involved,
each producing a small effect. Advances in genetics have confirmed what the
GWAS suggested, that complex traits such as reading are the work of thousands
of genetic variants, working in concert (see Chapter 99 ). Thus, pediatricians
should be wary of recommending any genetic test to their patients that purports
to diagnose dyslexia in infancy or before language and reading have even
emerged. It is unlikely that a single gene or even a few genes will reliably
identify people with dyslexia. Rather, dyslexia is best explained by multiple
genes , each contributing a small amount toward the expression of dyslexia.
Epidemiology
Dyslexia is the most common and most comprehensively studied of the learning
disabilities, affecting 80% of children identified as having a learning disability.
Dyslexia may be the most common neurobehavioral disorder affecting children,
with prevalence rates ranging from 20% in unselected population-based samples
to much lower rates in school-identified samples. The low prevalence rate in
school-identified samples may reflect the reluctance of schools to identify
dyslexia. Dyslexia occurs with equal frequency in boys and girls in survey
samples in which all children are assessed. Despite such well-documented
findings, schools continue to identify more boys than girls, probably reflecting
the more rambunctious behavior of boys who come to the teacher's attention
because of misbehavior, while girls with reading difficulty, who are less likely to
be misbehaving, are also less likely to be identified by the schools. Dyslexia fits
a dimensional model in which reading ability and disability occur along a
continuum, with dyslexia representing the lower tail of a normal distribution of
reading ability.
Pathogenesis
Evidence from a number of lines of investigation indicates that dyslexia reflects
deficits within the language system, and more specifically, within the
phonologic component of the language system engaged in processing the
sounds of speech. Individuals with dyslexia have difficulty developing an
awareness that spoken words can be segmented into smaller elemental units of
sound (phonemes), an essential ability given that reading requires that the reader
map or link printed symbols to sound. Increasing evidence indicates that
disruption of attentional mechanisms may also play an important role in reading
difficulties.
Functional brain imaging in both children and adults with dyslexia
demonstrates an inefficient functioning of left hemisphere posterior brain
systems, a pattern referred to as the neural signature of dyslexia (Fig. 50.2 ).
Although functional magnetic resonance imaging (fMRI) consistently
demonstrates differences between groups of dyslexic compared to typical
readers, brain imaging is not able to differentiate an individual case of a dyslexic
reader from a typical reader and thus is not useful in diagnosing dyslexia.
FIG. 50.2 A neural signature for dyslexia. The left side of the figure shows a schematic
of left hemisphere brain systems in in typical (nonimpaired) readers. The 3 systems for
reading are an anterior system in the region of the inferior frontal gyrus (Broca's area),
serving articulation and word analysis, and 2 posterior systems, 1 in the
occipitotemporal region serving word analysis, and a 2nd in the occipitotemporal
region (the word-form area) serving the rapid, automatic, fluent identification of words.
In dyslexic readers (right side of figure), the 2 posterior systems are functioning
inefficiently and appear underactivated. This pattern of underactivation in left posterior
reading systems is referred to as the neural signature for dyslexia. (Adapted from
Shaywitz S: Overcoming dyslexia: a new and complete science-based program for
reading problems at any level. New York, 2003, Alfred A. Knopf. Copyright 2003 by S.
Shaywitz. Adapted with permission.)
Clinical Manifestations
Reflecting the underlying phonologic weakness, children and adults with
dyslexia manifest problems in both spoken and written language. Spoken
language difficulties are typically manifest by mispronunciations, lack of
glibness, speech that lacks fluency with many pauses or hesitations and “ums,”
word-finding difficulties with the need for time to summon an oral response, and
the inability to come up with a verbal response quickly when questioned; these
reflect sound-based, not semantic or knowledge-based, difficulties.
Struggles in decoding and word recognition can vary according to age and
developmental level. The cardinal signs of dyslexia observed in school-age
children and adults are a labored, effortful approach to reading involving
decoding, word recognition, and text reading. Listening comprehension is
typically robust. Older children improve reading accuracy over time, but without
commensurate gains in reading fluency; they remain slow readers. Difficulties in
spelling typically reflect the phonologically based difficulties observed in oral
reading. Handwriting is often affected as well.
History often reveals early subtle language difficulties in dyslexic children.
During the preschool and kindergarten years, at-risk children display difficulties
playing rhyming games and learning the names for letters and numbers.
Kindergarten assessments of these language skills can help identify children at
risk for dyslexia. Although a dyslexic child enjoys and benefits from being read
to, the child might avoid reading aloud to the parent or reading independently.
Dyslexia may coexist with attention-deficit/hyperactivity disorder (see
Chapter 49 ); this comorbidity has been documented in both referred samples
(40% comorbidity) and nonreferred samples (15% comorbidity).
Diagnosis
A large achievement gap between typical and dyslexic readers is evident as early
as 1st grade and persists (Fig. 50.3 ). These findings provide strong evidence and
impetus for early screening and identification of and early intervention for young
children at risk for dyslexia. One source of potentially powerful and highly
accessible screening information is the teacher's judgment about the child's
reading and reading-related skills. Evidence-based screening can be carried out
as early as kindergarten, and also in grades 1-3, by the child's teacher. The
teachers' responses to a small set of questions (10-12 questions) predict a pool of
children who are at risk for dyslexia with a high degree of accuracy. Screening
takes less than 10 minutes, is completed on a tablet, and is extremely efficient
and economical. Children found to be at-risk will then have further assessment
and, if diagnosed as dyslexic, should receive evidence-based intervention.
FIG. 50.3 Reading from grades 1 through 9 in typical and dyslexic readers. The
achievement gap between typical and dyslexic readers is evident as early as 1st grade
and persists through adolescence. (Adapted from Ferrer E, Shaywitz BA, Holahan JM, et
al: Achievement gap in reading is present as early as first grade and persists through
adolescence, J Pediatr 167:1121–1125, 2015.)
Management
The management of dyslexia demands a life-span perspective. Early in life the
focus is on remediation of the reading problem. Applying knowledge of the
importance of early language, including vocabulary and phonologic skills, leads
to significant improvements in children's reading accuracy, even in predisposed
children. As a child matures and enters the more time-demanding setting of
middle and then high school, the emphasis shifts to the important role of
providing accommodations. Based on the work of the National Reading Panel,
evidence-based reading intervention methods and programs are identified.
Effective intervention programs provide systematic instruction in 5 key areas:
phonemic awareness, phonics, fluency, vocabulary, and comprehension
strategies. These programs also provide ample opportunities for writing, reading,
and discussing literature.
Taking each component of the reading process in turn, effective interventions
improve phonemic awareness: the ability to focus on and manipulate phonemes
(speech sounds) in spoken syllables and words. The elements found to be most
effective in enhancing phonemic awareness , reading, and spelling skills
include teaching children to manipulate phonemes with letters; focusing the
instruction on 1 or 2 types of phoneme manipulations rather than multiple types;
and teaching children in small groups. Providing instruction in phonemic
awareness is necessary but not sufficient to teach children to read. Effective
intervention programs include teaching phonics , or making sure that the
beginning reader understands how letters are linked to sounds (phonemes) to
form letter-sound correspondences and spelling patterns. The instruction should
be explicit and systematic; phonics instruction enhances children's success in
learning to read, and systematic phonics instruction is more effective than
instruction that teaches little or no phonics or teaches phonics casually or
haphazardly. Important but often overlooked is starting children on reading
connected text early on, optimally at or near the beginning of reading instruction.
Fluency is of critical importance because it allows the automatic, rapid
recognition of words, and while it is generally recognized that fluency is an
important component of skilled reading, it has proved difficult to teach.
Interventions for vocabulary development and reading comprehension are not as
well established. The most effective methods to teach reading comprehension
involve teaching vocabulary and strategies that encourage active interaction
between the reader and the text. Emerging science indicates that it is not only
teacher content knowledge but the teacher's skill in engaging the student and
focusing the student's attention on the reading task at hand that is required for
effective instruction.
For those in high school, college, and graduate school, provision of
accommodations most often represents a highly effective approach to dyslexia.
Imaging studies now provide neurobiologic evidence of the need for extra time
for dyslexic students; accordingly, college students with a childhood history of
dyslexia require extra time in reading and writing assignments as well as
examinations. Many adolescent and adult students have been able to improve
their reading accuracy, but without commensurate gains in reading speed. The
accommodation of extra time reconciles the individual's often high cognitive
ability and slow reading, so that the exam is a measure of that person's ability
rather than his disability. Another important accommodation is teaching the
dyslexic student to listen to texts. Excellent text-to-speech programs and apps
available for Apple and Android systems include Voice Dream Reader,
Immersive Reader (in OneNote as part of Microsoft Office), Kurzweil Firefly,
Read & Write Gold, Read: OutLoud, and Natural Reader. Voice-to-text programs
are also helpful, often part of the suite of programs as well as the popular Dragon
Dictate. Voice to text is found on many smartphones. Other helpful
accommodations include the use of laptop computers with spelling checkers,
access to lecture notes, tutorial services, and a separate quiet room for taking
tests.
In addition, the impact of the primary phonologic weakness in dyslexia
mandates special consideration during oral examinations so that students are not
graded on their lack of glibness or speech hesitancies but on their content
knowledge. Unfortunately, speech hesitancies or difficulties in word retrieval
often are wrongly confused with insecure content knowledge. The major
difficulty in dyslexia, reflecting problems accessing the sound system of spoken
language, causes great difficulty learning a 2nd language. As a result, an often-
necessary accommodation is a waiver or partial waiver of the foreign language
requirement; the dyslexic student may enroll in a course on the history or culture
of a non–English-speaking country.
Prognosis
Application of evidence-based methods to young children (kindergarten to grade
3), when provided with sufficient intensity and duration, can result in
improvements in reading accuracy and, to a much lesser extent, fluency. In older
children and adults, interventions result in improved accuracy, but not an
appreciable improvement in fluency. Accommodations are critical in allowing
the dyslexic child to demonstrate his or her knowledge. Parents should be
informed that with proper support, dyslexic children can succeed in a range of
future occupations that might seem out of their reach, including medicine, law,
journalism, and writing.
Bibliography
Ferrer E, Shaywitz BA, Holahan JM, et al. Uncoupling of
reading and IQ over time: empirical evidence for a definition
of dyslexia. Psychol Sci . 2010;21(1):93–101.
Ferrer E, Shaywitz BA, Holahan JM, et al. Achievement gap in
reading is present as early as first grade and persists through
adolescence. J Pediatr . 2015;167:1121–1125.
Herrera-Araujo D, Shaywitz BA, Holahan JM, et al. Evaluating
willingness to pay as a measure of the impact of dyslexia in
adults. J Benefit Cost Anal . 2017;8(1):4–48.
Hulme C, Snowling MJ. Reading disorders and dyslexia. Curr
Opin Pediatr . 2016;28:731–735.
National Reading Panel. Teaching children to read: an evidence
based assessment of the scientific research literature on
reading and its implications for reading instruction, NIH Pub
No 00-4754 . US Department of Health and Human Services,
Public Health Service, National Institutes of Health, National
Institute of Child Health and Human Development: Bethesda,
MD; 2000.
Romberg F, Shaywitz BA, Shaywitz SE. How should medical
schools respond to students with dyslexia? AMA J Ethics .
2016;18(10):975–984.
Shaywitz S. Overcoming dyslexia: a new and complete science-
based program for reading problems at any level . Alfred A
Knopf: New York; 2003.
Shaywitz SE: Shaywitz DyslexiaScreen. The Shaywitz
DyslexiaScreen is an efficient, reliable, and user-friendly
dyslexia test for K-1. This screening tool identifies students
who are at risk for dyslexia. Available from Pearson Clinical.
Shaywitz SE, Shaywitz BA. Dyslexia (specific reading
disability). Biol Psychiatry . 2005;57:1301–1309.
Shaywitz BA, Weiss LG, Saklofske DH, Shaywitz SE.
Translating scientific progress in dyslexia into 21st century
diagnosis and interventions. Weiss LG, Saklofske DH,
Holdnack JA, Prifitera A. WISC-V Clinical use and
interpretation: a scientist-practitioner perspective . Elsevier:
San Diego; 2016:269–286.
Shaywitz S, Shaywitz B, Wietecha L, et al. Effect of
atomoxetine treatment on reading and phonological skills in
children with dyslexia or attention-deficit/hyperactivity
disorder and comorbid dyslexia in a randomized, placebo-
controlled trial. J Child Adolesc Psychopharmacol .
2017;27(1):19–28.
US Senate Resolution 576. Calling on Congress, schools, and
State and local educational agencies to recognize the
significant educational implications of dyslexia that must be
addressed . [Washington, DC] 2016 [114th Congress, 2nd
Session ed].
CHAPTER 51
51.1
Math Disabilities
Kenneth L. Grizzle
Keywords
dyscalculia
math disability
Individual with Disabilities Education Act
IDEA
individualized education plan
IEP
response to intervention
specific learning disorder with impairment in mathematics
Data from the U.S. National Center for Educational Statistics for 2009 showed
that 69% of U.S. high school graduates had taken algebra 1, 88% geometry, 76%
algebra 2/trigonometry, and 35% precalculus. These percentages are
considerably higher than those for 20 years earlier. However, concerns remain
about the limited literacy level in mathematics for children, adolescents, and
those entering the workforce; poor math skills predict numerous social,
employment, and emotional challenges. The need for number and math literacy
extends beyond the workplace and into daily lives, and weaknesses in this area
can negatively impact daily functioning. Research into the etiology and
treatment of math disabilities falls far behind the study of reading disabilities
(see Chapter 50 ). Therefore the knowledge needed to identify, treat, and
minimize the impact of math challenges on daily functioning and education is
limited.
Terminology
The term dyscalculia , often used in medicine and research but seldom used by
educators, is reserved for children with a SLD in math when there is a pattern of
deficits in learning arithmetic facts and accurate, fluent calculations. The term
math learning disability (MLD ) is used generically here, with dyscalculia used
when limiting the discussion to children with deficient math calculation skills. A
distinction is also made between children with a MLD and those who are low
achieving (LA) in math; both groups have received considerable research
focus. Although not included in either definition above, research into math
deficits typically requires that individuals identified with MLD have math
achievement scores below the 10th percentile across multiple grade levels. These
children start out poorly in math and continue poor performance across grades,
despite interventions. LA math students consistently score below the 25th
percentile on math achievement tests across grades, but show more typical entry-
level math skills.
Epidemiology
Prevalence
Depending on how MLD is defined and assessed, the prevalence varies. Based
on findings from multiple studies, approximately 7% of children will show a
MLD profile before high school graduation. An additional 10% of students will
be identified as LA. Because research in the area typically requires that
individuals show deficits for consecutive years, the respective prevalence
estimates are lower than the 10th percentile cutoff for being identified as MLD
or the 25th percentile cutoff for being identified as LA. It is not unusual for
children to score below the criterion one year and above the criterion in
subsequent years. These children do not show the same cognitive deficits
associated with a MLD. Unlike dyslexia, boys are at greater risk to experience
MLD. This is found in epidemiologic research in the United States (risk ratio,
1.6-2.2 : 1) and various European countries.
Risk Factors
Genetics
The heritability of math skills is estimated to be approximately 0.50. The
heritability or genetic influence on math skills is consistent across the continuum
from high to low math skills. This research emphasizes that although math skills
are learned across time, the stability of math performance is the result of genetic
influences. Math heritability appears to be the product of multiple genetic
markers, each having a small effect.
Medical/Genetic Conditions
Numerous genetic syndromes are associated with math problems. Although most
children with fragile X syndrome have an intellectual disability (ID),
approximately 50% of girls with the condition do not. Of those without an ID,
≥75% have a math disability by the end of 3rd grade and are already scoring
below average in mathematics in kindergarten and 1st grade. For girls with
fragile X MLD, weak working memory seems to play an important role. The
frequency of MLD in girls with Turner syndrome (TS) is the same as found in
girls with fragile X syndrome. A consistent finding is girls with TS complete
math calculations at significantly slower speed than typically developing
students. Although girls with TS have weak calculation skills, their ability to
complete math problems not requiring explicit calculation is similar to that of
their peers. The percentage of children with the 22q11.2 deletion syndrome
(22q11.2ds) with MLD is not clear. Younger children with this genetic condition
(6-10 yr old) showed similar number sense and calculation skills as typically
developing children but weaker math problem solving. Older children with
22q11.2ds showed slower speed in their general number sense and calculations,
but accuracy was maintained. Weak counting skills and magnitude comparison
have been found in this group of children, suggesting weak visual-spatial
processing. Children with myelomeningocele are at greater risk for math
difficulties than their unaffected peers. Almost 30% of these children have MLD
without an additional diagnosed learning disorder, and >50% have both math
and reading learning disorders. While broad, deficits are most pronounced in
speed of math calculation and written computation.
Comorbidities
It is estimated that 30–70% of those with MLD will also have reading disability.
This is especially important because children with MLD are less likely to be
referred for additional educational assistance and intervention than students with
reading problems. Unfortunately, children identified with both learning
challenges perform poorer across psychosocial and academic measures than
children with MLD alone. Having a MLD places a child at greater risk for not
only other learning challenges but also psychiatric disorders, including attention-
deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder,
generalized anxiety disorder, and major depressive disorder. Individuals with
MLD have been found to have increased social isolation and difficulties
developing social relationships in general.
Working Memory
Working memory refers to the ability to keep information in mind while using
the information in other mental processes. Working memory is composed of 3
core systems: the central executive, the language-related phonologic loop, and
the visual-based sketch pad. The central executive coordinates the functioning of
the other two systems. All three play a role in various aspects of learning and in
the development and application of math skills in particular; children with MLD
have shown deficits in each area.
Processing Speed
Individuals with MLD are often slower to complete math problems than their
typically developing peers, a result of their poor fact retrieval rather than broader
speed of processing deficits. However, young children later identified with a
MLD when beginning school have number-processing speed that is considerably
slower than same-age same-grade peers.
Math-Specific Processes
Procedural Errors
The type of errors made by children with a MLD are typical for any child, the
difference being that children with a learning disability show a 2-3 yr lag in
understanding the concept. An example of a common error a 1st grade child with
a MLD might make when “counting on” is to undercount: “6 + 2= ?;” “6, 7”
rather than starting at 6 and counting an additional 2 numbers. As children with
math deficits get older, it is common to subtract a larger number from a smaller
number. For example, in the problem “63 − 29 = 46,” the child makes the
mistake of subtracting 3 from 9. Another common error is not decreasing the
number in the 10s column when borrowing: “64 − 39 = 35.” For both adding and
subtracting, there is a lack of understanding of the commutative property of
numbers and a tendency to use repeated addition rather than fact retrieval. It is
not that children with a MLD do not develop these skills, it is that they develop
them much later than their peers, thereby making the transition to complicated
math concepts much more challenging.
Awareness that most public school systems have implemented some form of a
RtI to identify learning disabilities allows the primary care physician to
encourage parents to return to the school seeking an intervention to address their
child's concern. Receiving special education services in the form of an IEP may
be necessary for some children. However, the current approach to identifying
children with a learning disability allows school systems to intervene earlier,
when problems arise, and potentially avoid the need for an IEP. Pediatricians
with patients whose parents have received feedback from school with any of the
risk factors outlined in Table 51.2 should encourage the parents to discuss an
intervention plan with the child's teacher.
Table 51.2
Risk Factors for a Specific Learning
Disability Involving Mathematics
The child is at or below the 20th percentile in any math area, as reflected
by standardized testing or ongoing measures of progress monitoring.
The teacher expresses concerns about the child's ability to “take the next
step” in math.
There is a positive family history for math learning disability (this alone
will not initiate an intervention).
Parents think they have to “reteach” math concepts to their child.
Bibliography
Bartelet D, Ansari D, Vaessen A, Blomert L. Cognitive subtypes
of mathematics learning difficulties in primary education. Res
Dev Disabil . 2014;35(3):657–670.
Chodura S, Kuhn JT, Holling H. Interventions for children with
mathematical difficulties: a meta-analysis. Z Psychol .
2015;223(2):129–144.
Docherty SJ, Davis OSP, Kovas Y, et al. Genome-wide
association study identifies multiple loci associated with
mathematics ability and disability. Genes Brain Behav .
2010;9:234–247.
Geary DC. Mathematical cognition deficits in children with
learning disabilities and persistent low achievement: a five-
year prospective study. J Educ Psychol . 2012;104(1):206–
223.
Kaufman L, Mazzocco MM, Dowker A, et al. Dyscalculia from
a developmental and differential perspective. Front Psychol .
2013;4:1–5.
Kucian K. Developmental dyscalculia and the brain. Berch DB,
Geary DC, Koepke KM. Development of mathematical
cognition: neural substrates and genetic influences . Elsevier:
New York; 2016:165–193.
Mazzocco M. Mathematics awareness month: why should
pediatricians be aware of mathematics and numeracy? J Dev
Behav Pediatr . 2016;37:251–253.
Mazzocco MM, Quintero AI, Murphy MM, McCloskey M.
Genetic syndromes as model pathways to mathematical
learning difficulties: fragile X, Turner and 22q deletion
syndromes. Berch DB, Geary DC, Koepke KM. Development
of mathematical cognition: neural substrates and genetic
influences . Elsevier: New York; 2016:325–357.
Petrill SA, Kovas Y. Individual differences in mathematics
ability: a behavioral genetic approach. Berch DB, Geary DC,
Koepke KM. Development of mathematical cognition: neural
substrates and genetic influences . Elsevier: New York;
2016:299–324.
Shin MS, Bryant DP. A synthesis of mathematical and cognitive
performances of students with mathematics learning
disabilities. J Learn Disabil . 2015;48:96–112.
51.2
Writing Disabilities
Kenneth L. Grizzle
Keywords
dysgraphia
transcription
specific language impairment
pragmatic language
higher-level language
executive functions
working memory
504 plan
individual education plan
Oral language is a complex process that typically develops in the absence of
formal instruction. In contrast, written language requires instruction in
acquisition (word reading), understanding (reading comprehension), and
expression (spelling and composition). Unfortunately, despite reasonable
pedagogy, a subset of children struggle with development in one or several of
these areas. The disordered output of written language is currently referred to
within the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition
(DSM-5) as a specific learning disorder with impairment in written
expression (Table 51.3 ).
Table 51.3
DSM-5 Diagnostic Criteria for Specific
Learning Disability With Impairment in
Written Expression
A. Difficulties learning and using academic skills that have persisted for at
least 6 mo, despite the provision of interventions that target those
difficulties.
Difficulties with written expression (e.g., makes multiple
grammatical or punctuation errors within sentences; employs
poor paragraph organization; written expression of ideas lacks
clarity).
B. The affected academic skills are substantially and quantifiably below those
expected for the individual's chronological age, and cause significant
interference with academic or occupational performance, or with activities
of daily living, as confirmed by individually administered standardized
achievement measures and comprehensive clinical assessment. For
individuals age 17 yr and older, a documented history of impairing learning
difficulties may be substituted for the standardized assessment.
C. The learning difficulties begin during school-age years but may not
become fully manifest until the demands for those affected academic skills
exceed the individual's limited capacities (e.g., as in timed tests, reading or
writing lengthy complex reports for a tight deadline, excessively heavy
academic loads).
D. The learning difficulties are not better accounted for by intellectual
disabilities, uncorrected visual or auditory acuity, other mental or
neurologic disorders, psychosocial adversity, lack of proficiency in the
language of academic instruction, or inadequate educational instruction.
Adapted from the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition, (Copyright 2013). American Psychiatric Association, pp 66–67.
Various terminology has been used when referring to individuals with writing
deficits; this subchapter uses the term impairment in written expression (IWE)
rather than “writing disorder” or “disorder of written expression.” Dysgraphia is
often used when referring to children with writing problems, sometimes
synonymously with IWE, although the two are related but distinct conditions.
Dysgraphia is primarily a deficit in motor output (paper/pencil skills), and IWE
is a conceptual weakness in developing, organizing, and elaborating on ideas in
writing.
The diagnoses of a IWE and dysgraphia are made largely based on
phenotypical presentation; spelling, punctuation, grammar, clarity, and
organization are factors to consider with IWE concerns. Aside from these
potentially weak writing characteristics, however, no other guidelines are
offered. Based on clinical experience and research into the features of writing
samples of children with disordered writing skills, one would expect to see
limited output, poor organization, repetition of content, and weak sentence
structure and spelling, despite the child taking considerable time to produce a
small amount of content. For those with comorbid dysgraphia, the legibility of
their writing product will also be poor, sometimes illegible.
Epidemiology
The incidence of IWE is estimated at 6.9–14.7%, with the relative risk for IWE
2-2.9 times higher for boys than girls. One study covering three U.S. geographic
regions found considerably higher rates of IWE in the Midwest and Southeast
than in the West.
The risk for writing problems is much greater among select populations;
>50% of children with oral language disorders reportedly have IWE. The
relationship between attention-deficit/hyperactivity disorder (ADHD) and
learning disorders in general is well established, including IWE estimates in the
60% range for the combined and inattentive presentations of ADHD. Because of
the importance of working memory and other executive functions in the writing
process, any child with weakness in these areas will likely find the writing
process difficult (see Chapter 48 ).
Transcription
Among preschool and primary grade children, there is a wide range of what is
considered “developmentally typical” as it relates to letter production and
spelling. However, evidence indicates that poor writers in later grades are slow
to produce letters and write their name in preschool and kindergarten. Weak
early spelling and reading skills (letter identification and phonologic awareness;
see Chapter 50 ) and weak oral language have also been found to predict weak
writing skills in later elementary grades. Children struggling to master early
transcription skills tend to write slowly, or when writing at reasonable speed,
the legibility of their writing degrades. Output in quantity and variety is limited,
and vocabulary use in poor spellers is often restricted to words they can spell.
As children progress into upper elementary school and beyond, a new set of
challenges arise. They are now expected to have mastered lower-level
transcription skills, and the focus turns to the application of these skills to more
complex text generation. In addition to transcription, this next step requires the
integration of additional cognitive skills that have yet to be tapped by young
learners.
Oral Language
Language, although not speech, has been found to be related to writing skills.
Writing difficulties are associated with deficits in both expression and
comprehension of oral language. Writing characteristics of children with specific
language impairment (SLI) can differ from their unimpaired peers early in the
school experience, and persist through high school (see Chapter 52 ). In
preschool and kindergarten, as a group, children with language disorders show
poorer letter production and ability to print their name. Poor spelling and weak
vocabulary also contribute to the poor writing skills. Beyond primary grades, the
written narratives of SLI children tend to be evaluated as “lower quality with
poor organization” and weaker use of varied vocabulary.
Pragmatic language and higher-level language deficits also negatively impact
writing skills. Pragmatic language refers to the social use of language,
including, though not limited to greeting and making requests; adjustments to
language used to meet the need of the situation or listener; and following
conversation rules verbally and nonverbally. Higher-level language goes
beyond basic vocabulary, word form, and grammatical skills and includes
making inferences, understanding and appropriately using figurative language,
and making cause-and-effect judgments. Weaknesses in these areas, with or
without intact foundational language, can present challenges for students in all
academic areas that require writing. For example, whether producing an analytic
or narrative piece, the writer must understand the extent of the reader's
background knowledge and in turn what information to include and omit, make
an argument for a cause-and-effect relationship, and use content-specific
vocabulary or vocabulary rich in imagery and nonliteral interpretation.
Executive Functions
Writing is a complicated process and, when done well, requires the effective
integration of multiple processes. Executive functions (EFs) are a set of skills
that include planning, problem solving, monitoring and making adjustments as
needed (see Chapter 48 ). Three recursive processes have consistently been
reported as involved in the writing process: translation of thought into written
output, planning, and reviewing. Coming up with ideas, while challenging for
many, is simply the first step when writing a narrative (story). Once an idea has
emerged, the concept must be developed to include a plot, characters, and story
line and then coordinated into a coherent whole that is well organized and flows
from beginning to end. Even if one develops ideas and begins to write them
down, persistence is required to complete the task, which requires self-
regulation. Effective writers rely heavily on EFs, and children with IWE struggle
with this set of skills. Poor writers seldom engage in the necessary planning and
struggle to self-monitor and revise effectively.
Working Memory
Working memory (WM) refers to the ability to hold, manipulate, and store
information for short periods. The more space available, the more memory can
be devoted to problem solving and thinking tasks. Nevertheless, there is limited
space in which information can be held, and the more effort devoted to one task,
the less space is available to devote to other tasks. WM has consistently been
shown to play an important role in the writing process, because weak WM limits
the space available. Further, when writing skills that are expected to be
automatic continue to require effort, precious memory is required, taking away
what would otherwise be available for higher-level language.
The Simple View of Writing is an approach that integrates each of the 4 ideas
just outlined to describe the writing process (Fig. 51.1 ). At the base of the
triangle are transcription and executive functions, which support, within WM,
the ability to produce text. Breakdowns in any of these areas can lead to poor
writing, and identifying where the deficit(s) are occurring is essential when
deciding to treat the writing problem. For example, children with weak
graphomotor skills (e.g., dysgraphia) must devote considerable effort to the
accurate production of written language, thereby increasing WM use devoted to
lower-level transcription and limiting memory that can be used for developing
discourse. The result might be painfully slow production of a legible story, or a
passage that is largely illegible. If, on the other hand, a child's penmanship and
spelling have developed well, but their ability to persist with challenging tasks or
to organize their thoughts and develop a coordinated plan for their paper is
limited, one might see very little information written on the paper despite
considerable time devoted to the task. Lastly, even when skills residing at the
base of this triangle are in place, students with a language disorder will likely
produce text that is more consistent with their language functioning than their
chronological grade or age (Fig. 51.1 ).
FIG. 51.1 Simple view of writing. (From Berninger VW: Preventing written expression
disabilities through early and continuing assessment and intervention for handwriting
and/or spelling problems: research into practice. In Swanson HL, Harris KR, Graham S,
editors: Handbook of learning disabilities, New York, 2003, The Guilford Press.)
Treatment
Poor writing skills can improve with effective treatment. Weak graphomotor
skills may not necessarily require intervention from an occupational therapist
(OT), although Handwriting Without Tears is a curriculum frequently used by
OTs when working with children with poor penmanship. An empirically
supported writing program has been developed by Berninger, but it is not widely
used inside or outside school systems (PAL Research-Based Reading and Writing
Lessons). For children with dysgraphia, lower-level transcription skills should be
emphasized to the point of becoming automatic. The connection between
transcription skills and composition should be included in the instructional
process; that is, children need to see how their work at letter production is
related to broader components of writing. Further, because of WM constraints
that frequently impact the instructional process for students with learning
disorders, all components of writing should be taught within the same lesson.
Explicit instruction of writing strategies combined with implementation and
coaching in self-regulation will likely produce the greatest gains for students
with writing deficits. Emphasis will vary depending on the deficit specific to the
child. A well-researched and well-supported intervention for poor writers is self-
regulated strategy development (SRSD) . The 6 stages in this model include
developing and activating a child's background knowledge; introducing and
discussing the strategy that is being taught; modeling the strategy for the student;
assisting the child in memorization of the strategy; supporting the child's use of
the strategy during implementation; and independent use of the strategy. SRSD
can be applied across various writing situations and is supported until the student
has developed mastery. The model can emphasize or deemphasize the areas most
needed by the child.
Educational Resources
Children with identified learning disorders can potentially qualify for formal
education programming through special education or a section 504 plan. Special
education is guided on a federal level by the Individual with Disabilities
Education Act (IDEA) and includes development of an individual education
plan (see Chapter 48 ). A 504 plan provides accommodations to help children
succeed in the regular classroom. Accommodations that might be provided to a
child with IWE, through an IEP or a 504 plan, include dictation to a scribe when
confronted with lengthy writing tasks, additional time to complete exams that
require writing, and use of technology such as keyboarding, speech-to-text
software, and writing devices that record teacher instruction. When
recommending that parents pursue assistive technology for their child as a
potential accommodation, the physician should emphasize the importance of
instruction to mastery of the device being used. Learning to use technology
effectively requires considerable time and is initially likely to require additional
effort, which can result in frustration and avoidance.
Bibliography
Andrews JE, Lombardino LJ. Strategies for teaching
handwriting to children with writing disabilities. Perspect
Lang Learn Educ . 2014;21:114–126.
Berninger VW. Preventing written expression disabilities
through early and continuing assessment and intervention for
handwriting and/or spelling problems: research into practice.
Swanson HL, Harris KR, Graham S. Handbook of learning
disabilities . The Guilford Press: New York; 2003:35–363.
Berninger VW. Process assessment of the learner (PAL):
research-based reading and writing lessons . Psychological
Corporation: San Antonio, TX; 2003.
Berninger VW. Interdisciplinary frameworks for schools: best
professional practices for serving the needs of all students .
American Psychological Association: Washington, DC; 2015.
Berninger VW, May MO. Evidence-based diagnosis and
treatment for specific learning disabilities involving
impairments in written and/or oral language. J Learn Disabil
. 2011;44(2):167–183.
Dockrell JE. Developmental variations in the production of
written text: challenges for students who struggle with
writing. Stone CA, Silliman ER, Ehren BJ, Wallach GP.
Handbook of language and literacy . ed 2. The Guilford
Press: New York; 2014:505–523.
Dockrell JE, Lindsay G, Connelly V. The impact of specific
language impairment on adolescents' written text. Except
Child . 2009;75(4):427–446.
Graham S, Harris KR. Writing better: effective strategies for
teaching students with learning difficulties . Paul H Brookes
Publishing: Baltimore; 2005.
Katusic SK, Colligan RC, Weaver AL, Barbaresi WJ. The
forgotten learning disability: epidemiology of written-
language disorder in a population-based birth cohort (1976-
1982), Rochester, Minnesota. Pediatrics . 2009;123(5):1306–
1313.
Paul R, Norbury C. Language disorders from infancy through
adolescence: listening, speaking, reading, writing, and
communicating . Elsevier: St Louis; 2012.
Silliman ER, Berninger VW. Cross-disciplinary dialogue about
the nature of oral and written language problems in the
context of developmental, academic, and phenotypic profiles.
Top Lang Disord . 2011;31:6–23.
Stoeckel RE, Colligan RC, Barbaresi WJ, et al. Early speech-
language impairment and risk for written language disorder: a
population-based study. J Dev Behav Pediatr .
2013;34(1):38–44.
Sun L, Wallach GP. Language disorders are learning disabilities:
challenges on the divergent and diverse paths to language
learning disability. Top Lang Disord . 2014;34:25–38.
Williams GJ, Larkin RF, Blaggan S. Written language skills in
children with specific language impairment. Int J Lang
Commun Disord . 2013;48(2):160–171.
CHAPTER 52
Variations of Normal
Language milestones have been found to be largely universal across languages
and cultures, with some variations depending on the complexity of the
grammatical structure of individual languages. In Italian (where verbs often
occupy a prominent position at the beginning or end of sentences), 14 mo olds
produce a greater proportion of verbs compared with English speaking infants.
Within a given language, development usually follows a predictable pattern,
paralleling general cognitive development. Although the sequences are
predictable, the exact timing of achievement is not. There are marked variations
among normal children in the rate of development of babbling, comprehension
of words, production of single words, and use of combinational forms within the
first 2-3 yr of life.
Two basic patterns of language learning have been identified, analytic and
holistic. The analytic pattern is the most common and reflects the mastery of
increasingly larger units of language form. The child's analytic skills proceed
from simple to more complex and lengthy forms. Children who follow a holistic
or gestalt learning pattern might start by using relatively large chunks of speech
in familiar contexts. They might memorize familiar phrases or dialog from
movies or stories and repeat them in an overgeneralized fashion. Their sentences
often have a formulaic pattern, reflecting inadequate mastery of the use of
grammar to flexibly and spontaneously combine words appropriately in the
child's own unique utterance. Over time, these children gradually break down the
meanings of phrases and sentences into their component parts, and they learn to
analyze the linguistic units of these memorized forms. As this occurs, more
original speech productions emerge, and the child is able to assemble thoughts in
a more flexible manner. Both analytic and holistic learning processes are
necessary for normal language development to occur.
Etiology
Normal language ability is a complex function that is widely distributed across
the brain through interconnected neural networks that are synchronized for
specific activities. Although clinical similarities exist between acquired aphasia
in adults and childhood language disorders, unilateral focal lesions acquired in
early life do not seem to have the same effects in children as in adults. Risk
factors for neurologic injury are absent in the vast majority of children with
language impairment.
Genetic factors appear to play a major role in influencing how children learn
to talk. Language disorders cluster in families. A careful family history may
identify current or past speech or language problems in up to 30% of first-degree
relatives of proband children. Although children exposed to parents with
language difficulty might be expected to experience poor language stimulation
and inappropriate language modeling, studies of twins have shown the
concordance rate for low language test score and/or a history of speech therapy
to be approximately 50% in dizygotic pairs, rising to over 90% in monozygotic
pairs. Despite strong evidence that language disorders have a genetic basis,
consistent genetic mutations have not been identified. Instead, multiple genetic
regions and epigenetic changes may result in heterogeneous genetic pathways
causing language disorders. Some of these genetic pathways disrupt the timing
of early prenatal neurodevelopmental events affecting migration of nerve cells
from the germinal matrix to the cerebral cortex. Several single nucleotide
polymorphisms (SNPs) involving noncoding regulatory genes, including
CNTNAP2 (contactin-associated-protein-like-2) and KIAA0319 , are strongly
associated with early language acquisition and are also believed to affect early
neuronal structural development.
In addition, other environmental, hormonal, and nutritional factors may exert
epigenetic influences by dysregulating gene expression and resulting in aberrant
sequencing of the onset, growth, and timing of language development .
Pathogenesis
Language disorders are associated with a fundamental deficit in the brain's
capacity to process complex information rapidly. Simultaneous evaluation of
words (semantics), sentences (syntax), prosody (tone of voice), and social cues
can overtax the child's ability to comprehend and respond appropriately in a
verbal setting. Limitations in the amount of information that can be stored in
verbal working memory can further limit the rate at which language information
is processed. Electrophysiologic studies show abnormal latency in the early
phase of auditory processing in children with language disorders. Neuroimaging
studies identify an array of anatomic abnormalities in regions of the brain that
are central to language processing. MRI scans in children with specific language
impairment (SLI) may reveal white matter lesions and volume loss, ventricular
enlargement, focal gray matter heterotopia within the right and left
parietotemporal white matter, abnormal morphology of the inferior frontal gyrus,
atypical patterns of asymmetry of language cortex, or increased thickness of the
corpus callosum in a minority of affected children. Postmortem studies of
children with language disorders found evidence of atypical symmetry in the
plana temporale and cortical dysplasia in the region of the sylvian fissure. In
support of a genetic mechanism affecting cerebral development, a high rate of
atypical perisylvian asymmetries has also been documented in the parents of
children with SLI.
Clinical Manifestations
Primary disorders of speech and language development are often found in the
absence of more generalized cognitive or motor dysfunction. However, disorders
of communication are also the most common comorbidities in persons with
generalized cognitive disorders (intellectual disability or autism), structural
anomalies of the organs of speech (e.g., velopharyngeal insufficiency from cleft
palate), and neuromotor conditions affecting oral motor coordination (e.g.,
dysarthria from cerebral palsy or other neuromuscular disorders).
Classification
Each professional discipline has adopted a somewhat different classification
system, based on cluster patterns of symptoms. The American Psychiatric
Association (APA) Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5) organized communication disorders into: (1) language disorder
(which combines expressive and mixed receptive-expressive language
disorders), speech sound disorder (phonologic disorder), and childhood-onset
fluency disorder (stuttering); and (2) social (pragmatic) communication disorder,
which is characterized by persistent difficulties in the social uses of verbal and
nonverbal communication (Table 52.2 ). In clinical practice, childhood speech
and language disorders occur as a number of distinct entities.
Table 52.2
DSM-5 Diagnostic Criteria for
Communication Disorders
Language Disorder
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
(Copyright 2013). American Psychiatric Association, pp 42, 44, 47–48.
Intellectual Disability
Most children with a mild degree of intellectual disability learn to talk at a
slower-than-normal rate; they follow a normal sequence of language acquisition
and eventually master basic communication skills. Difficulties may be
encountered with higher-level language concepts and use. Persons with moderate
to severe degrees of intellectual disability can have great difficulty in acquiring
basic communication skills. About half of persons with an intelligence quotient
(IQ) of <50 can communicate using single words or simple phrases; the rest are
typically nonverbal.
Asperger Syndrome
Asperger syndrome is characterized by difficulties in social interaction,
eccentric behaviors, and abnormally intense and circumscribed interests despite
normal cognitive and verbal ability. Affected individuals may engage in long-
winded, verbose monologs about their topics of special interest, with little regard
to the reaction of others. Adults with Asperger syndrome generally have a more
favorable prognosis of than those with “classic” autism. Prior to 2013, Asperger
syndrome was classified as distinct from autism; however, DSM-5 no longer
recognizes Asperger as a separate neurodevelopmental disorder. More severely
affected individuals are now considered to be at the “high functioning” end of
the autism spectrum (see Chapter 54 ), whereas mildly impaired individuals may
be diagnosed with SPCD.
Selective Mutism
Selective mutism is defined as a failure to speak in specific social situations
despite speaking in other situations, and it is typically a symptom of an
underlying anxiety disorder . Children with selective mutism can speak
normally in certain settings, such as within their home or when they are alone
with their parents. They fail to speak in other social settings, such as at school or
at other places outside their home. Other symptoms associated with selective
mutism can include excessive shyness, withdrawal, dependency on parents, and
oppositional behavior. Most cases of selective mutism are not the result of a
single traumatic event, but rather the manifestation of a chronic pattern of
anxiety. Mutism is not passive-aggressive behavior. Selectively mute children
often report that they want to speak in social settings but are afraid to do so.
Often, one or both parents of a child with selective mutism has a history of
anxiety symptoms, including childhood shyness, social anxiety, or panic attacks.
Mutism is highly functional for the child in that it reduces anxiety and protects
the child from the perceived challenge of social interaction. Treatment of
selective mutism should utilize cognitive behavioral strategies focused on
reducing the general anxiety and increasing speaking in social situation (see
Chapter 38 ). Occasionally, selective serotonin reuptake inhibitors are helpful in
conjunction with cognitive-behavioral therapy. Selective mutism reflects a
difficulty of social interaction, not a disorder of language processing.
Hearing Impairment
Hearing loss can be a major cause of delayed or disordered language
development (see Chapter 655 ). Approximately 16-30 per 1,000 children have
mild to severe hearing loss, significant enough to affect educational progress. In
addition to these “hard of hearing” children, approximately another 1 : 1,000 are
deaf (profound bilateral hearing loss). Hearing loss can be present at birth or
acquired postnatally. Newborn screening programs can identify many forms of
congenital hearing loss, but children can develop progressive hearing loss or
acquire deafness after birth.
The most common types of hearing loss are attributable to conductive (middle
ear) or sensorineural deficit. Although it is not possible to accurately predict the
impact of hearing loss on a child's language development, the type and degree of
hearing loss, the age of onset, and the duration of the auditory impairment
clearly play important roles. Children with significant hearing impairment often
have problems developing facility with language and often have related
academic difficulties. Presumably, the language impairment is caused by lack of
exposure to fluent language models, starting in infancy.
Approximately 30% of hearing-impaired children have at least 1 other
disability that affects development of speech and language (e.g., intellectual
disability, cerebral palsy, craniofacial anomalies). Any child who shows
developmental warning signs of a speech or language problem should have a
hearing assessment by an audiologist.
Hydrocephalus
Some children with hydrocephalus may be described as having “cocktail-party
syndrome.” Although they may use sophisticated words, their comprehension of
abstract concepts is limited, and their pragmatic conversational skills are weak.
As a result, they speak superficially about topics and appear to be carrying on a
monolog (see Chapter 609.11 ).
Table 52.3
Speech and Language Screening
REFER FOR SPEECH–LANGUAGE EVALUATION IF:
AT RECEPTIVE EXPRESSIVE
AGE
15 Does not look/point at 5-10 objects Is not using 3 words
mo
18 Does not follow simple directions (“get Is not using Mama, Dada, or other names
mo your shoes”)
24 Does not point to pictures or body parts Is not using 25 words
mo when they are named
30 Does not verbally respond or nod/shake Is not using unique 2-word phrases, including noun–verb
mo head to questions combinations
36 Does not understand prepositions or Has a vocabulary of <200 words; does not ask for things;
mo action words; does not follow 2-step echolalia to questions; language regression after attaining 2-
directions word phrases
Diagnostic Evaluation
It is important to distinguish developmental delay (abnormal timing) from
abnormal patterns or sequences of development. A child's language and
communication skills must also be interpreted within the context of the child's
overall cognitive and physical abilities. It is also important to evaluate the child's
use of language to communicate with others in the broadest sense
(communicative intent). Thus a multidisciplinary evaluation is often warranted.
At a minimum, this should include psychologic evaluation, neurodevelopmental
pediatric assessment, and speech-language examination.
Psychologic Evaluation
There are two main goals for the psychologic evaluation of a young child with a
communication disorder. Nonverbal cognitive ability must be assessed to
determine if the child has an intellectually disability, and the child's social
behaviors must be assessed to determine whether ASD is present. Additional
diagnostic considerations may include emotional disorders such as anxiety,
depression, mood disorder, obsessive-compulsive disorder, academic learning
disorders, and attention-deficit/hyperactivity disorder (ADHD).
Cognitive Assessment
Intellectual disability is defined as deficits in cognitive abilities and adaptive
behaviors. In this context, children with intellectual disability show delayed
development of communication skills; however, delayed communication does
not necessarily signal intellectual disability. Therefore, a broad-based cognitive
assessment is an important component to the evaluation of children with
language delays, including evaluation of both verbal and nonverbal skills. If a
child has intellectual disability, both verbal and nonverbal scores will be low
compared to norms (≤2nd percentile). In contrast, a typical cognitive profile for
a child with SLI includes a significant difference between nonverbal and verbal
abilities, with nonverbal IQ being greater than verbal IQ and the nonverbal score
being within an average range.
Medical Evaluation
Careful history and physical examination should focus on the identification of
potential contributors to the child's language and communication difficulties. A
family history of delay in talking, need for speech and language therapy, or
academic difficulty can suggest a genetic predisposition to language disorders.
Pregnancy history might reveal risk factors for prenatal developmental
anomalies, such as polyhydramnios or decreased fetal movement patterns. Small
size for gestational age at birth, symptoms of neonatal encephalopathy, or early
and persistent oral-motor feeding difficulty may presage speech and language
difficulty. Developmental history should focus on the age when various
language skills were mastered and the sequences and patterns of milestone
acquisition. Regression or loss of acquired skills should raise immediate
concern.
Physical examination should include measurement of height (length), weight,
and head circumference. The skin should be examined for lesions consistent with
phakomatosis (e.g., tuberous sclerosis, neurofibromatosis, Sturge-Weber
syndrome) and other disruptions of pigment (e.g., hypomelanosis of Ito).
Anomalies of the head and neck, such as white forelock and hypertelorism
(Waardenburg syndrome), ear malformations (Goldenhar syndrome), facial and
cardiac anomalies (Williams syndrome, velocardiofacial syndrome),
retrognathism of the chin (Pierre Robin anomaly), or cleft lip/palate, are
associated with hearing and speech abnormalities. Neurologic examination
might reveal muscular hypertonia or hypotonia, both of which can affect
neuromuscular control of speech. Generalized muscular hypotonia, with
increased range of motion of the joints, is frequently seen in children with SLI.
The reason for this association is not clear, but it might account for the fine and
gross motor clumsiness often seen in these children. However, mild hypotonia is
not a sufficient explanation for the impairment of expressive and receptive
language.
No routine diagnostic studies are indicated for SLI or isolated language
disorders. When language delay is a part of a generalized cognitive or physical
disorder, referral for further genetic evaluation, chromosome testing (e.g., fragile
X testing, microarray comparative genomic hybridization), neuroimaging
studies, and EEG may be considered, if clinically indicated.
Treatment
The federal Individuals with Disabilities Education Act (IDEA) requires that
schools provide early intervention and special education services to children
who have learning difficulties. This includes children with speech and language
disorders. Services are provided to children from birth through 21 yr of age.
States have various methods for providing services, including speech and
language therapy for young children, such as Birth-to-Three , Early Childhood ,
and Early Learning programs. Children can also receive therapy from nonprofit
service agencies, hospital and rehabilitation centers, and speech pathologists in
private practice.
Of concern is that many children with identified speech and language deficits
do not receive appropriate intervention services. Population-based surveys in
both the United States and Canada have found that less than half of children
identified by kindergarten entry receive speech and language interventions ,
even when their parents have been educated about the nature of their child's
condition. In one study, children with deficits in speech sound production were
much more likely to receive services (41%) than those who had problems with
language alone (9%). These findings are troubling because poor educational
outcome, especially in reading, and impaired social-behavioral adjustment are
more highly associated with language than with speech sound disorders.
Therefore the children at greatest risk are least likely to receive intervention
services. Boys were twice as likely to receive speech intervention as girls,
regardless of their speech-language diagnosis. Social and demographic factors
did not appear to influence whether identified children received interventions
services.
Speech-language therapy includes a variety of goals. Sometimes both speech
and language activities are incorporated in therapy. The speech goals focus on
development of more intelligible speech. Language goals can focus on
expanding vocabulary (lexicon) and understanding of the meaning of words
(semantics), improving syntax by using proper forms or learning to expand
single words into sentences, and social use of language (pragmatics). Therapy
can include individual sessions, group sessions, and mainstream classroom
integration. Individual sessions may use drill activities for older children or play
activities for younger children to target specific goals. Group sessions can
include several children with similar language goals to help them practice peer
communication activities and to help them bridge the gap into more naturalistic
communication situations. Classroom integration might include the therapist
team-teaching or consulting with the teacher to facilitate the child's use of
language in common academic situations.
For children with severe language impairment, alternative methods of
communication are often included in therapy, such as manual sign language, use
of pictures (e.g., Picture Exchange Communication System), and computerized
devices for speech output. Often the ultimate goal is to achieve better spoken
language. Early use of signs or pictures can help the child establish better
functional communication and understand the symbolic nature of words to
facilitate the language process. There is no evidence that use of signs or pictures
interferes with development of oral language if the child has the capacity to
speak. Many clinicians believe that these alternative methods accelerate the
learning of language. These methods also reduce the frustration of parents and
children who cannot communicate for basic needs.
Parents can consult with their child's speech-language therapist about home
activities to enhance language development and extend therapy activities
through appropriate language-stimulating activities and recreational reading.
Parents' language activities should focus on emerging communication skills that
are within the child's repertoire, rather than teaching the child new skills. The
speech pathologist can guide parents on effective modeling and eliciting
communication from their child.
Recreational reading focuses on expanding the child's comprehension of
language. Sometimes the child's avoidance of reading is a sign that the parent is
presenting material that is too complex for the child. The speech-language
therapist can guide the parent in selecting an appropriate level of reading
material.
Prognosis
Children with mild isolated expressive language disorder (“late talkers”) have an
excellent prognosis for both language, learning, and social-emotional
adjustment.
Over time, children with SLI respond to therapeutic/educational interventions
and show a trend toward improvement of communication skills. Adults with a
history of childhood language disorder continue to show evidence of impaired
language ability, even when surface features of the communication difficulty
have improved considerably. This suggests that many persons find successful
ways of adapting to their impairment. Although the majority of children improve
their communication ability with time, 50–80% of preschoolers with language
delay and normal nonverbal intelligence continue to experience difficulty with
language and social development up to 20 yr beyond the initial diagnosis.
Language disorders often interfere with the child's ability to conceptualize the
increasingly complex and ambiguous worlds of social relationship and emotions.
Consequently, in later childhood and adolescence, children with persisting
symptoms of SLI are about twice as likely as their typical-language peers to
show clinical levels of emotional problems and twice as likely to show
behavioral difficulties.
A Danish study found that adults with SLI were less likely to have completed
formal education beyond high school, and that they had lower occupational and
socioeconomic success than the general population; 56% had a paid job (vs 84%
of same-age general population), of whom 35% were unskilled and 40% skilled
workers. About 80% of the adults reported difficulty reading while in school,
most had received remedial teaching, and 50% continued to report reading
difficulty as adults (vs 5% of Danish adults). Lower nonverbal intelligence and
comorbid psychiatric or neurologic disorders independently contributed to a
worse prognosis. These results were consistent with previous reports of adult
outcomes of children with SLI from Canada and the United Kingdom.
Academic Disorders
Early language difficulty is strongly related to later reading disorder .
Approximately 50% of children with early language difficulty develop reading
disorder, and 55% of children with reading disorder have a history of impaired
early oral language development. By the time they enter kindergarten, many
children with early language deficits may have improved significantly, and they
may begin to show early literacy skills, identifying and sounding out letters.
However, as they progress through school, they are often unable to keep up with
the increasing demands for both oral and written language. Despite their ability
to read words, these children lack oral and reading comprehension, may read
slowly, and struggle with a wide range of academic subjects. This “illusory
recovery” of early language skill may result in children losing speech-language
services or other special education support in early grades, only to be identified
later with academic problems. In addition, children with subtle but persisting
language impairments may appear inattentive or anxious in language-rich
classroom environments and may be misdiagnosed as having an attention
disorder.
A study from Australia found that at 7-9 yr of age, children with
communication impairments were reported by their parents and teachers to be
making slower progress in reading, writing, and overall school achievement than
other children their age. The children reported a higher incidence of bullying,
poorer peer relationships, and less overall enjoyment of school than their
typically developing peers.
Comorbid Disorders
Emotional and Behavioral Difficulty
Early language disorder, particularly difficulty with auditory comprehension,
appears to be a specific risk factor for later emotional dysfunction. Boys and
girls with language disorder have a higher-than-expected rate of anxiety
disorder (principally social phobia). Boys with language disorder are more
likely to develop symptoms of ADHD, conduct disorder, and antisocial
personality disorder compared with normally developing peers. Language
disorders are common in children referred for psychiatric services, but they are
often underdiagnosed, and their impact on children's behavior and emotional
development is often overlooked.
Preschoolers with language difficulty frequently express their frustration
through anxious, socially withdrawn, or aggressive behavior. As their ability to
communicate improves, parallel improvements are usually noted in their
behavior, suggesting a cause-and-effect relationship between language and
behavior. However, the persistence of emotional and behavioral problems over
the life span of persons with early language disability suggests a strong biologic
or genetic connection between language development and subsequent emotional
disorders.
The full impact of environmental and education support on these emotional
and behavioral difficulties is not known at this time, but many children with SLI
need psychologic support. Efforts should be made to support the child's
resilience, emotional competency, and coping abilities. Parents and teachers
should be encouraged to strengthen the child's prosocial behavior and reduce
noncompliant and aggressive behaviors.
52.1
Childhood-Onset Fluency Disorder
Kenneth L. Grizzle
Keywords
childhood-onset fluency disorder
cluttering
physical concomitants
stammering, stuttering
Table 52.4
A. Disturbances in the normal fluency and time patterning of speech that are
inappropriate for the individual's age and language skills, persist over time,
and are characterized by frequent and marked occurrences of one (or more)
of the following:
1. Sound and syllable repetitions.
2. Sound prolongations of consonants as well as vowels.
3. Broken words (e.g., pauses within a word).
4. Audible or silent blocking (filled or unfilled pauses in speech).
5. Circumlocutions (word substitutions to avoid problematic words).
6. Words produced with an excess of physical tension.
7. Monosyllabic whole-word repetitions (e.g., “I-I-I-I see him”).
B. The disturbance causes anxiety about speaking or limitations in effective
communication, social participation, or academic or occupational
performance, individually or in any combination.
C. The onset of symptoms is in the early developmental period.
Note: Later-onset cases are diagnosed as 307.0 [F98.5] adult-onset fluency
disorder.
D. The disturbance is not attributable to a speech-motor or sensory deficit,
dysfluency associated with neurologic insult (e.g., stroke, tumor, trauma),
or another medical condition and is not better explained by another mental
disorder.
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
(Copyright 2013). American Psychiatric Association, pp 45–46.)
Epidemiology
Although prevalence studies have produced a range of estimates for
developmental stuttering, it appears that 0.75–1% of the population is
experiencing this condition at any one time. Incidence rates are considerably
higher: Estimates to date suggest an incidence rate of approximately 5%, with
rates considerably higher among young children than older children or
adolescents. Seldom does a child begin stuttering before 2 yr of age or after 12
yr; in fact, the mean age of onset is 2-4 yr, and most children stop stuttering
within 4 yr of onset. Symptoms will disappear within 4 wk for a minority of
children. Although studies have consistently shown that the male:female ratio
favors males, the magnitude of the pattern increases as children get older. The
ratio among children <5 yr is approximately 2 : 1 and jumps to 4 : 1 among
adolescents and young adults.
Genetics
There is convergent evidence of a genetic link for childhood-onset fluency
disorder. Concordance rates among MZ twins range from 20–83%, and for DZ
twins, 4–19%. Family aggregation studies suggest increased incidence rate of
approximately 15% among first-degree relatives of those affected, 3 times higher
than the 5% rate for the general population. The variance in risk for stuttering
attributed to genetic effects is high, ranging from 70–85%. Although evidence is
limited, stuttering appears to be a polygenic condition, and several genes
increase susceptibility.
Etiology
Brain structure and function abnormalities found in stutterers include deficits in
white matter in the left hemisphere, overactivity in the right cortical region, and
underactivity in the auditory cortex. Abnormal basal ganglia activation has also
been identified among stutterers.
Comorbidities
Despite the widely held belief in a high degree of comorbidity between
childhood-onset fluency disorder and other communication disorders, research to
date does not necessarily support this assertion. Speech-language pathologists
(SLPs) consistently report higher rates of comorbidity on their caseload,
although this would be expected in clinical samples. Speech sound (phonologic)
disorders are the most commonly reported comorbidities, and 30–40% of
children on SLP caseloads are also experiencing problems with phonology.
However, studies have not found greater incidence of phonologic disorders
among those who stutter compared to a control group. Similarly, SLPs report a
much higher percentage of children with language disorders among their patients
who stutter than the approximately 7% expected in the population at large, yet
the language functioning among stutters apparently is no different than in the
general population. The same pattern holds for learning disorder (LD). The
incidence of various types of LDs associated with a language disorder is well
documented, so one would expect to see increased frequency within a clinical
population.
The perception of communication disorder professionals and people in general
is that children who stutter experience more anxiety than their nonstuttering
peers. This in fact is supported by clinical research that has found considerably
higher rates of psychopathology, specifically social anxiety and generalized
anxiety disorder, among adolescents who stutter. The frequency of reported
anxiety increases with age. To date, however, the lack of controlled studies
should not lead to the assumption that stuttering itself places a child or
adolescent at greater risk for a psychiatric disorder of any type. This is not meant
to suggest that anxiety has no impact on a stuttering child's behavior in specific
situations; as indicated earlier in this chapter, children who stutter frequently
avoid situations that demand speaking.
Children who stutter have consistently been found to be bullied more than
peers. In one study, stutterers were almost 4 times more likely to be bullied than
their nonstuttering counterparts. About 45% of those who stuttered reported
being the victim of bullying.
Developmental Progression
Onset of stuttering typically occurs between 2 and 4 yr of age. Severity of
symptoms vary, from pronounced stuttering within a few days of onset to
gradual worsening of symptoms across months. Symptoms may ebb and flow,
including disappearing for weeks before returning, especially among young
children. From 40–75% of young children who stutter will stop spontaneously,
typically within months of starting. Although predicting which child will stop
stuttering is difficult, risk factors for persisting include stuttering for >1 yr,
continued stuttering after age 6 yr, and experiencing other speech or language
problems.
Treatment
Several factors should be considered when deciding to refer a younger child with
childhood-onset fluency disorder for therapy. If there is a positive family history
for stuttering, if symptoms have been present for >4 wk, and if the dysfluencies
are impacting the child's social, behavioral, and emotional functioning, referral is
warranted. Although there is no cure for stuttering, behavioral therapies are
available that are developed and implemented by SLPs. Treatment emphasizes
managing stuttering while speaking by regulating rate of speech and breathing
and helping the child gradually progress from the fluent production of syllables
to more complex sentences. Approaches to treatment may include parents
directly in the process, although even if not active participants, parents play an
important role in the child coping with stuttering. Treatment in preschool-age
children has been shown to improve stuttering. Management of stuttering is also
emphasized in older children. For school-age children, treatment includes
improving not only fluency but also concomitants of the condition. This includes
recognizing and accepting stuttering and appreciating others' reaction to the child
when stuttering, managing secondary behaviors, and addressing avoidance
behaviors. The broad focus allows for minimizing the adverse effects of the
condition. To date, no evidence supports the use of a pharmacologic agent to
treat stuttering in children and adolescents.
Preschool children with normal developmental dysfluency can be observed
with parental education and reassurance. Parents should not reprimand the child
or create undue anxiety.
Preschool or older children with stuttering should be referred to a speech
pathologist. Therapy is most effective if started during the preschool period. In
addition to the risks noted in Table 52.5 , indications for referral include 3 or
more dysfluencies per 100 syllables (b-b-but; th-th-the; you, you, you),
avoidances or escapes (pauses, head nod, blinking), discomfort or anxiety while
speaking, and suspicion of an associated neurologic or psychotic disorder.
Most preschool children respond to interventions taught by speech
pathologists and to behavioral feedback by parents. Parents should not yell at the
child, but should calmly praise periods of fluency (“That was smooth”) or
nonjudgmentally note episodes of stuttering (“That was a bit bumpy”). The child
can be involved with self-correction and respond to requests (“Can you say that
again?”) made by a calm parent. Such treatment greatly improves dysfluency,
but it may never be eliminated.
Bibliography
American Psychiatric Association. Diagnostic and statistical
manual of mental disorders . ed 5. American Psychiatric
Publishing: Washington, DC; 2013.
Conture EG, Yaruss JS. Treatment efficacy summary: stuttering,
American Speech and Hearing Association website .
http://www.asha.org/uploadedFiles/public/TESStuttering.pdf .
Craig A, Tran Y. Trait and social anxiety in adults with chronic
stuttering: conclusions following meta-analysis. J Fluency
Disord . 2014;40:35–43.
Gunn A, Menzies RG, O'Brian S, et al. Axis I anxiety and
mental health disorders among stuttering adolescents. J
Fluency Disord . 2014;40:58–68.
Laiho A, Klippi A. Long- and short-term results of children's
and adolescents' therapy courses for stuttering. Int J Lang
Commun Disord . 2007;42(3):367–382.
McAllister J. Behavioural, emotional and social development of
children who stutter. J Fluency Disord . 2016;50:23–32.
Nippold MA. Stuttering and language ability in children:
questioning the connection. Am J Speech Lang Pathol .
2011;21:183–196.
Sasisekaran J. Exploring the link between stuttering and
phonology: a review and implications for treatment. Semin
Speech Lang . 2014;35(2):95–113.
Yiari Ehud, Seery Carol H. Stuttering: foundations and clinical
applications . ed 2. Pearson Education: Upper Saddle River,
NJ; 2015.
Bibliography
Billard C, Fluss J, Pinton F. Specific language impairment
versus Landau-Kleffner syndrome. Epilepsia . 2009;50(Suppl
7):21–24.
Boyle J. Speech and language delays in preschool children.
BMJ . 2011;343:d5181.
Clegg J, Hollis C, Mawhood L, et al. Developmental language
disorder—a follow-up in later adult life: cognitive, language
and psychosocial outcomes. J Child Psychol Psychiatry .
2005;46:128–149.
Cohen NJ, Barwick MA, Horodezky NB, et al. Language,
achievement, and cognitive processing in psychiatrically
disturbed children with previously identified and unsuspected
language impairments. J Child Psychol Psychiatry .
1998;39:865–877.
De Fosse L, Hodge SM, Makris N, et al. Language-association
cortex asymmetry in autism and specific language
impairment. Ann Neurol . 2004;56:757–766.
Dehaene-Lambertz G, Montavont A, Jobert A, et al. Language
or music, mother or Mozart? Structural and environmental
influences on infants' language networks. Brain Lang .
2010;114:53–65.
Elbro C, Dalby M, Maarbjerg S. Language-learning
impairments: a 30-year follow-up of language-impaired
children with and without psychiatric, neurological and
cognitive difficulties. Int J Lang Commun Disord .
2011;46:437–448.
Feinberg AP. Phenotypic plasticity and the epigenetics of
human disease. Nature . 2007;447:433–440.
Flapper BCT, Schoemaker MM. Developmental coordination
disorder in children with specific language impairment: co-
morbidity and impact on quality of life. Res Dev Disabil .
2013;34:756–763.
Herbert MR, Kenet T. Brain abnormalities in language disorders
and in autism. Pediatr Clin North Am . 2007;54:563–583.
Hua A, Major N. Selective mutism. Curr Opin Pediatr .
2016;28:114–120.
Johnson CJ, Beitchman JH, Young A, et al. Fourteen-year
follow-up of children with and without speech/language
impairments: speech/language stability and outcomes. J
Speech Lang Hear Res . 1999;42:744–760.
Kennedy CR, McCann DC, Campbell MJ, et al. Language
ability after early detection of permanent childhood hearing
impairment. N Engl J Med . 2006;354:2131–2140.
May L, Byers-Heinlein K, Gervain J, et al. Language and the
newborn brain: does prenatal language experience shape the
neonate neural response to speech? Front Psychol .
2011;2:222.
McCormack J, Harrison LJ, McLeod S, et al. A nationally
representative study of the association between
communication impairment at 4-5 years and children's life
activities at 7-9 years. J Speech Lang Hear Res .
2011;54:1328–1348.
Siu AL. Screening for speech and language delay and disorders
in children aged 5 years or younger: US Preventive Services
Task Force Recommendation Statement. Pediatrics .
2015;136:e448–e462.
Peterson RL, Pennington BF. Developmental dyslexia. Lancet .
2012;379(9830):1997–2007.
Reilly S, Onslow M, Packman A, et al. Predicting stuttering
onset by the age of 3 years: a prospective, community cohort
study. Pediatrics . 2009;123:270–277.
Rice ML. Toward epigenetic and gene regulation models of
specific language impairment: looking for links among
growth, genes, and impairments. J Neurodev Disord .
2012;4:27–41.
Roberts JE, Rosenfeld RM, Zeisel SA. Otitis media and speech
and language: a meta-analysis of prospective studies.
Pediatrics . 2004;113(3 Pt 1):e238–e248.
Schum R. Language screening in the pediatric office setting.
Pediatr Clin North Am . 2007;54:425–436.
Simms MD, Jin X. Autism, language disorder, social
(pragmatic) communication disorder, and DSM-V. Pediatr
Rev . 2015;38:355–362.
Stefanatos G. Changing perspectives on Landau-Kleffner
syndrome. Clin Neuropsychol . 2011;25:963–988.
Tager-Flusberg H, Caronna E. Language disorders: autism and
other pervasive developmental disorders. Pediatr Clin North
Am . 2007;54:469–481.
Tierney CD, Kurtz M, Souders H. Clear as mud: another look at
autism, childhood apraxia of speech and auditory processing.
Curr Opin Pediatr . 2012;24:394–399.
US Preventive Services Task Force. Screening for speech and
language delay in preschool children: recommendation
statement. Pediatrics . 2006;117:497–501.
Wake M, Tobin S, Girolametto L, et al. Outcomes of population
based language promotion for slow to talk toddlers at ages 2
and 3 years: Let's Learn Language cluster randomised
controlled trial. BMJ . 2011;343:d4741.
Wallace IF, Berkman ND, Watson LR, et al. Screening for
speech and language delay in children 5 years old and
younger: a systematic review. Pediatrics . 2015;136(2):e448–
e462.
Ward D. The aetiology and treatment of developmental
stammering in childhood. Arch Dis Child . 2008;93:68–71.
Whitehouse AJO, Robinson M, Zubrick SR. Late talking and
the risk for psychosocial problems during childhood and
adolescence. Pediatrics . 2011;128:e324–e332.
Yew SG, O'Kearney R. Emotional and behavioural outcomes
later in childhood and adolescence for children with specific
language impairments: meta-analyses of controlled
prospective studies. J Child Psychol Psychiatry .
2013;54(5):516–524.
Zhang X, Tomblin JB. The association of intervention receipt
with speech-language profiles and social-demographic
variables. Am J Speech Lang Pathol . 2000;9:345–357.
Zumach A, Gerritis E, Chenault M, et al. Long-term effects of
early-life otitis media on language development. J Speech
Lang Hear Res . 2010;53:34–43.
CHAPTER 53
Definition
Contemporary conceptualizations of ID emphasize functioning and social
interaction rather than test scores. The definitions of ID by the World Health
Organization (WHO) International Classification of Diseases, Tenth Edition
(ICD-10), the U.S. Individuals with Disabilities Education Act (IDEA), the
American Psychiatric Association (APA) Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-5), and the American Association on
Intellectual and Developmental Disabilities (AAIDD) all include significant
impairment in general intellectual function (reasoning, learning, problem
solving), social skills, and adaptive behavior. This focus on conceptual, social,
and practical skills enables the development of individual treatment plans
designed to enhance functioning. Consistent across these definitions is onset of
symptoms before age 18 yr or adulthood.
Significant impairment in general intellectual function refers to performance
on an individually administered test of intelligence that is approximately 2
standard deviations (SD) below the mean. Generally these tests provide a
standard score that has a mean of 100 and SD of 15, so that intelligence quotient
(IQ) scores <70 would meet these criteria. If the standard error of measurement
is considered, the upper limits of significantly impaired intellectual function may
extend to an IQ of 75. Using a score of 75 to delineate ID might double the
number of children with this diagnosis, but the requirement for impairment of
adaptive skills limits the false positives. Children with ID often show a variable
pattern of strengths and weaknesses. Not all their subtest scores on IQ tests fall
into the significantly impaired range.
Significant impairment in adaptive behavior reflects the degree that the
cognitive dysfunction impairs daily function. Adaptive behavior refers to the
skills required for people to function in their everyday lives. The AAIDD and
DSM-5 classifications of adaptive behavior addresses three broad sets of skills:
conceptual, social, and practical. Conceptual skills include language, reading,
writing, time, number concepts, and self-direction. Social skills include
interpersonal skills, personal and social responsibility, self-esteem, gullibility,
naiveté, and ability to follow rules, obey laws, and avoid victimization.
Representative practical skills are performance of activities of daily living
(dressing, feeding, toileting/bathing, mobility), instrumental activities of daily
living (e.g., housework, managing money, taking medication, shopping,
preparing meals, using phone), occupational skills, and maintenance of a safe
environment. For a deficit in adaptive behavior to be present, a significant delay
in at least 1 of the 3 skill areas must be present. The rationale for requiring only
1 area is the empirically derived finding that people with ID can have varying
patterns of ability and may not have deficits in all 3 areas.
The requirement for adaptive behavior deficits is the most controversial aspect
of the diagnostic formulation. The controversy centers on two broad areas:
whether impairments in adaptive behavior are necessary for the construct of ID,
and what to measure. The adaptive behavior criterion may be irrelevant for many
children; adaptive behavior is impaired in virtually all children who have IQ
scores <50. The major utility of the adaptive behavior criterion is to confirm ID
in children with IQ scores in the 65-75 range. It should be noted that deficits in
adaptive behavior are often found in disorders such as autism spectrum disorder
(ASD; see Chapter 54 ) and attention-deficit/hyperactivity disorder (ADHD; see
Chapter 49 ) in the presence of typical intellectual function.
The issues of measurement are important as well. The independence of the 3
domains of adaptive behavior has not been validated. The relationship between
adaptive behavior and IQ performance is insufficiently explored. Most adults
with mild ID do not have significant impairments in practical skills. Adaptive
behavior deficits also must be distinguished from maladaptive behavior (e.g.,
aggression, inappropriate sexual contact).
Onset before age 18 yr or adulthood distinguishes dysfunctions that originate
during the developmental period. The diagnosis of ID may be made after 18 yr
of age, but the cognitive and adaptive dysfunction must have been manifested
before age 18.
The term “mental retardation” should not be used because it is stigmatizing,
has been used to limit the achievements of the individual, and has not met its
initial objective of assisting people with the disorder. The term intellectual
disability is increasingly used in its place, but has not been adopted universally.
In the United States, Rosa's law (Public Law 111-256) was passed in 2010 and
now mandates that the term mental retardation be stripped from federal health,
education, and labor policy. As of 2013, at least 9 states persist in using the
outdated terminology. In Europe the term learning disability is often used to
describe ID.
Global developmental delay (GDD) is a term often used to describe young
children whose limitations have not yet resulted in a formal diagnosis of ID. In
DSM-5, GDD is a diagnosis given to children <5 yr of age who display
significant delay (>2 SD) in acquiring early childhood developmental milestones
in 2 or more domains of development. These domains include receptive and
expressive language, gross and fine motor function, cognition, social and
personal development, and activities of daily living. Typically, it is assumed that
delay in 2 domains will be associated with delay across all domains evaluated,
but this is not always the case. Furthermore, not all children who meet criteria
for a GDD diagnosis at a young age go on to meet criteria for ID after age 5 yr.
Reasons for this might include maturational effects, a change in developmental
trajectory (possibly from an intervention), reclassification to a different disability
category, or imprecise use of the GDD diagnosis initially. Conversely, in patients
with more severe delay, the GDD term is often inappropriately used beyond the
point when the child clearly has ID, often by 3 yr of age.
It is important to distinguish the medical diagnosis of GDD from the federal
disability classification of “developmental delay” that may be used by education
agencies under IDEA. This classification requires that a child have delays in
only 1 domain of development with subsequent need for special education. Each
state determines its own precise definition and terms of eligibility under the
broader definition outline by IDEA, and many states use the label for children up
to age 9 yr.
Etiology
Numerous identified causes of ID may occur prenatally, during delivery,
postnatally, or later in childhood. These include infection, trauma, prematurity,
hypoxia-ischemia, toxic exposures, metabolic dysfunction, endocrine
abnormalities, malnutrition, and genetic abnormalities. However, more than two
thirds of persons with ID will not have a readily identifiable underlying
diagnosis that can be linked to their clinical presentation, meriting further
medical evaluation. For those who then undergo further genetic and metabolic
workup, about two thirds will have an etiology that is subsequently discovered.
There does appear to be 2 overlapping populations of children with ID with
differing corresponding etiologies. Mild ID (IQ 50-70) is associated more with
environmental influences, with the highest risk among children of low
socioeconomic status. Severe ID (IQ <50) is more frequently linked to biologic
and genetic causes. Accordingly, diagnostic yield is generally higher among
persons with more severe disability (>75%) than among those with mild
disability (<50%). With continued advancement of technologic standards and
expansion of our knowledge base, the number of identified biologic and genetic
causes is expected to increase.
Nongenetic risk factors that are often associated with mild ID include low
socioeconomic status, residence in a developing country, low maternal
education, malnutrition, and poor access to healthcare. The most common
biologic causes of mild ID include genetic or chromosomal syndromes with
multiple, major, or minor congenital anomalies (e.g., velocardiofacial, Williams,
and Noonan syndromes), intrauterine growth restriction, prematurity, perinatal
insults, intrauterine exposure to drugs of abuse (including alcohol), and sex
chromosomal abnormalities. Familial clustering is common.
In children with severe ID, a biologic cause (usually prenatal) can be
identified in about three fourths of all cases. Causes include chromosomal (e.g.,
Down, Wolf-Hirschhorn, and deletion 1p36 syndromes) and other genetic and
epigenetic disorders (e.g., fragile X, Rett, Angelman, and Prader-Willi
syndromes), abnormalities of brain development (e.g., lissencephaly), and inborn
errors of metabolism or neurodegenerative disorders (e.g.,
mucopolysaccharidoses) (Table 53.1 ). Nonsyndromic severe ID may be a result
of inherited or de novo gene mutations, as well as microdeletions or
microduplications not detected on standard chromosome analysis. Currently,
>700 genes are associated with nonsyndromic ID. Inherited genetic
abnormalities may be mendelian (autosomal dominant de novo, autosomal
recessive, X-linked) or nonmendelian (imprinting, methylation, mitochondrial
defects; see Chapter 97 ). De novo mutations may also cause other phenotypic
features such as seizures or autism; the presence of these features suggests more
pleotropic manifestations of genetic mutations. Consistent with the finding that
disorders altering early embryogenesis are the most common and severe, the
earlier the problem occurs in development, the more severe its consequences
tend to be.
Table 53.1
Epidemiology
The prevalence of ID depends on the definition, method of ascertainment, and
population studied, both in terms of geography and age. According to the
statistics of a normal distribution, 2.5% of the population should have ID (based
on IQ alone), and 75% of these individuals should fall into the mild to moderate
range. Variability in rates across populations likely results from the heavy
influence of external environmental factors on the prevalence of mild ID. The
prevalence of severe ID is relatively stable. Globally, the prevalence of ID has
been estimated to be approximately 16.4 per 1,000 persons in low-income
countries, approximately 15.9/1,000 for middle-income countries, and
approximately 9.2/1,000 in high-income countries. A meta-analysis of
worldwide studies from 1980–2009 yielded an overall prevalence of 10.4/1000.
ID occurs more in boys than in girls, at 2 : 1 in mild ID and 1.5 : 1 in severe ID.
In part this may be a consequence of the many X-linked disorders associated
with ID, the most prominent being fragile X syndrome (see Chapter 98.5 ).
In 2014–2015 in the United States, approximately 12/1000 students 3-5 yr old
and 6.2/1000 students 6-21 yr old received services for ID in federally supported
school programs. In 2012 the National Survey of Children's Health reported an
estimated prevalence of ID among American children (age 2-17 yr) of 1.1%. For
several reasons, fewer children than predicted are identified as having mild ID.
Because it is more difficult to diagnose mild ID than the more severe forms,
professionals might defer the diagnosis and give the benefit of the doubt to the
child. Other reasons that contribute to the discrepancy are use of instruments that
underidentify young children with mild ID, children diagnosed as having ASD
without their ID being addressed, misdiagnosis as a language disorder or specific
learning disability, and a disinclination to make the diagnosis in poor or minority
students because of previous overdiagnosis. In some cases, behavioral disorders
may divert the focus from the cognitive dysfunction.
Beyond potential underdiagnosis of mild ID, the number of children with mild
ID may be decreasing as a result of public health and education measures to
prevent prematurity and provide early intervention and Head Start programs.
However, although the number of schoolchildren who receive services under a
federal disability classification of ID has decreased since 1999, when
developmental delay is included in analysis of the data, the numbers have not
changed appreciably.
The prevalence of severe ID has not changed significantly since the 1940s,
accounting for 0.3–0.5% of the population. Many of the causes of severe ID
involve genetic or congenital brain malformations that can neither be anticipated
nor treated at present. In addition, new populations with severe ID have offset
the decreases in the prevalence of severe ID that have resulted from improved
healthcare. Although prenatal diagnosis and subsequent pregnancy terminations
could lead to a decreasing incidence of Down syndrome (see Chapter 98.2 ), and
newborn screening with early treatment has virtually eliminated ID caused by
phenylketonuria and congenital hypothyroidism, continued high prevalence of
fetal exposure to illicit drugs and improved survival of very-low-birthweight
premature infants has counterbalanced this effect.
Clinical Manifestations
Early diagnosis of ID facilitates earlier intervention, identification of abilities,
realistic goal setting, easing of parental anxiety, and greater acceptance of the
child in the community. Most children with ID first come to the pediatrician's
attention in infancy because of dysmorphisms, associated developmental
disabilities, or failure to meet age-appropriate developmental milestones (Tables
53.2 and 53.3 ). There are no specific physical characteristics of ID, but
dysmorphisms may be the earliest signs that bring children to the attention of the
pediatrician. They might fall within a genetic syndrome such as Down syndrome
or might be isolated, as in microcephaly or failure to thrive. Associated
developmental disabilities include seizure disorders, cerebral palsy, and ASD.
Table 53.2
Physical Examination of a Child With Suspected
Developmental Disabilities
Table 53.3
Most children with ID do not keep up with their peers' developmental skills.
In early infancy, failure to meet age-appropriate expectations can include a lack
of visual or auditory responsiveness, unusual muscle tone (hypo- or hypertonia)
or posture, and feeding difficulties. Between 6 and 18 mo of age, gross motor
delay (lack of sitting, crawling, walking) is the most common complaint.
Language delay and behavior problems are common concerns after 18 mo (Table
53.4 ). For some children with mild ID, the diagnosis remains uncertain during
the early school years. It is only after the demands of the school setting increase
over the years, changing from “learning to read” to “reading to learn,” that the
child's limitations are clarified. Adolescents with mild ID are typically up to date
on current trends and are conversant as to “who,” “what,” and “where.” It is not
until the “why” and “how” questions are asked that their limitations become
apparent. If allowed to interact at a superficial level, their mild ID might not be
appreciated, even by professionals, who may be their special education teachers
or healthcare providers. Because of the stigma associated with ID, adolescents
may use euphemisms to avoid being thought of as “stupid” or “retarded” and
may refer to themselves as learning disabled, dyslexic, language disordered, or
slow learners. Some people with ID emulate their social milieu to be accepted.
They may be social chameleons and assume the morals of the group to whom
they are attached. Some would rather be thought “bad” than “incompetent.”
Table 53.4
Diagnostic Evaluation
Intellectual disability is one of the most frequent reasons for referral to pediatric
genetic providers, with separate but similar diagnostic evaluation guidelines put
forth by the American College of Medical Genetics, the American Academy of
Neurology, the American Academy of Pediatrics (AAP), and the American
Academy of Child and Adolescent Psychiatry. ID is a diagnosis of great clinical
heterogeneity, with only a subset of syndromic etiologies identifiable through
classic dysmorphology. If diagnosis is not made after conducting an appropriate
history and physical examination, chromosomal microarray is the recommended
first step in the diagnostic evaluation of ID. Next-generation sequencing
represents the new diagnostic frontier, with extensive gene panels (exome or
whole genome) that increase the diagnostic yield and usefulness of genetic
testing in ID. Other commonly used medical diagnostic testing for children with
ID includes neuroimaging, metabolic testing, and electroencephalography (Fig.
53.1 ).
FIG. 53.1 Algorithm for the evaluation of the child with unexplained global
developmental delay (GDD) or intellectual disability (ID). AA, amino acids; ASD, autistic
spectrum disorder; CK, creatine kinase; CSF, cerebrospinal fluid; FBC, full blood count;
GAA, guanidinoacetic acid; GAG, glycosaminoglycans; LFT, liver function test; OA,
organic acids; TFT, thyroid function tests; TSC, tuberous sclerosis complex; U&E, urea
and electrolytes; VLCFA, very long chain fatty acids; WES, whole exome sequencing;
WGS, whole genome sequencing; X-linked intellectual disability genes.
Table 53.5
Table 53.6
Treatable Intellectual Disability Endeavor
(TIDE) Diagnostic Protocol
Tier 1: Nontargeted Metabolic Screening to Identify 54 (60%) Treatable
IEM
Blood
Plasma amino acids
Plasma total homocysteine
Acylcarnitine profile
Copper, ceruloplasmin
Urine
Organic acids
Purines and pyrimidines
Creatine metabolites
Oligosaccharides
Glycosaminoglycans
Amino acids (when indicated)
Audiology
Ophthalmology
Cytogenetic testing (array CGH)
Thyroid studies
Complete blood count (CBC)
Lead
Metabolic testing
Brain MRI and 1H spectroscopy (where available)
Fragile X
Targeted gene sequencing/molecular panel
Other
Some children with subtle physical or neurologic findings can also have
determinable biologic causes of their ID (see Tables 53.2 and 53.3 ). How
intensively one investigates the cause of a child's ID is based on the following
factors:
Differential Diagnosis
One of the important roles of pediatricians is the early recognition and diagnosis
of cognitive deficits. The developmental surveillance approach to early diagnosis
of ID should be multifaceted. Parents' concerns and observations about their
child's development should be listened to carefully. Medical, genetic, and
environmental risk factors should be recognized. Infants at high risk
(prematurity, maternal substance abuse, perinatal insult) should be registered in
newborn follow-up programs in which they are evaluated periodically for
developmental lags in the 1st 2 yr of life; they should be referred to early
intervention programs as appropriate. Developmental milestones should be
recorded routinely during healthcare maintenance visits. The AAP has
formulated a schema for developmental surveillance and screening (see Chapter
28 ).
Before making the diagnosis of ID, other disorders that affect cognitive
abilities and adaptive behavior should be considered. These include conditions
that mimic ID and others that involve ID as an associated impairment. Sensory
deficits (severe hearing and vision loss), communication disorders, refractory
seizure disorders, poorly controlled mood disorders, or unmanaged severe
attention deficits can mimic ID; certain progressive neurologic disorders can
appear as ID before regression is appreciated. Many children with cerebral palsy
(see Chapter 616.1 ) or ASD (Chapter 54 ) also have ID. Differentiation of
isolated cerebral palsy from ID relies on motor skills being more affected than
cognitive skills and on the presence of pathologic reflexes and tone changes. In
autism spectrum disorders, language and social adaptive skills are more
affected than nonverbal reasoning skills, whereas in ID, there are usually more
equivalent deficits in social, fine motor, adaptive, and cognitive skills.
Complications
Children with ID have higher rates of vision, hearing, neurologic, orthopedic,
and behavioral or emotional disorders than typically developing children. These
other problems are often detected later in children with ID. If untreated, the
associated impairments can adversely affect the individual's outcome more than
the ID itself.
The more severe the ID, the greater are the number and severity of associated
impairments. Knowing the cause of the ID can help predict which associated
impairments are most likely to occur. Fragile X syndrome and fetal alcohol
syndrome (see Chapter 126.3 ) are associated with a high rate of behavioral
disorders; Down syndrome has many medical complications (hypothyroidism,
obstructive sleep apnea, congenital heart disease, atlantoaxial subluxation).
Associated impairments can require ongoing physical therapy, occupational
therapy, speech-language therapy, behavioral therapy, adaptive and mobility
equipment, glasses, hearing aids, and medication. Failure to identify and treat
these impairments adequately can hinder successful habilitation and result in
difficulties in the school, home, and neighborhood environment.
Prevention
Examples of primary programs to prevent ID include the following:
Treatment
Although the core symptoms of ID itself are generally not treatable, many
associated impairments are amenable to intervention and therefore benefit from
early identification. Most children with an ID do not have a behavioral or
emotional disorder as an associated impairment, but challenging behaviors
(aggression, self-injury, oppositional defiant behavior) and mental illness (mood
and anxiety disorders) occur with greater frequency in this population than
among children with typical intelligence. These behavioral and emotional
disorders are the primary cause for out-of-home placements, increased family
stress, reduced employment prospects, and decreased opportunities for social
integration. Some behavioral and emotional disorders are difficult to diagnose in
children with more severe ID because of the child's limited abilities to
understand, communicate, interpret, or generalize. Other disorders are masked
by the ID. The detection of ADHD (see Chapter 49 ) in the presence of moderate
to severe ID may be difficult, as may be discerning a thought disorder
(psychosis) in someone with autism and ID.
Although mental illness is generally of biologic origin and responds to
medication, behavioral disorders can result from a mismatch between the
child's abilities and the demands of the situation, organic problems, and family
difficulties. These behaviors may represent attempts by the child to
communicate, gain attention, or avoid frustration. In assessing the challenging
behavior, one must also consider whether it is inappropriate for the child's
mental age, rather than the chronological age. When intervention is needed, an
environmental change, such as a more appropriate classroom setting, may
improve certain behavior problems. Behavior management techniques are
useful; psychopharmacologic agents may be appropriate in certain situations.
No medication has been found that improves the core symptoms of ID.
However, several agents are being tested in specific disorders with known
biologic mechanisms (e.g., mGluR5 inhibitors in fragile X syndrome, mTOR
inhibitors in tuberous sclerosis), with the hope for future pharmacologic options
that could alter the natural course of cognitive impairment seen in patients with
these disorders. Currently, medication is most useful in the treatment of
associated behavioral and psychiatric disorders. Psychopharmacology is
generally directed at specific symptom complexes, including ADHD (stimulant
medication), self-injurious behavior and aggression (antipsychotics), and
anxiety, obsessive-compulsive disorder, and depression (selective serotonin
reuptake inhibitors). Even if a medication proves successful, its use should be
reevaluated at least yearly to assess the need for continued treatment.
Primary Care
For children with an ID, primary care has the following important components:
Periodic Reevaluation
The child's abilities and the family's needs change over time. As the child grows,
more information must be provided to the child and family, goals must be
reassessed, and programming needs should be adjusted. A periodic review
should include information about the child's health status as well as the child's
functioning at home, at school, and in other community settings. Other
information, such as formal psychologic or educational testing, may be helpful.
Reevaluation should be undertaken at routine intervals (every 6-12 mo during
early childhood), at any time the child is not meeting expectations, or when the
child is moving from one service delivery system to another. This is especially
true during the transition to adulthood, beginning at age 16, as mandated by the
IDEA Amendments of 2004, and lasting through age 21, when care should be
transitioned to adult-based systems and providers.
Family Counseling
Many families adapt well to having a child with ID, but some have emotional or
social difficulties. The risks of parental depression and child abuse and neglect
are higher in this group of children than in the general population. The factors
associated with good family coping and parenting skills include stability of the
marriage, good parental self-esteem, limited number of siblings, higher
socioeconomic status, lower degree of disability or associated impairments
(especially behavioral), parents' appropriate expectations and acceptance of the
diagnosis, supportive extended family members, and availability of community
programs and respite care services. In families in whom the emotional burden of
having a child with ID is great, family counseling, parent support groups, respite
care, and home health services should be an integral part of the treatment plan.
Transition to Adulthood
Transition to adulthood in adolescents with intellectual disabilities can present a
stressful and chaotic time for both the individual and the family, just as it does
among young adults of typical intelligence. A successful transition strongly
correlates to later improved quality of life but requires significant advanced
planning. In moving from child to adult care, families tend to find that policies,
systems, and services are more fragmented, less readily available, and more
difficult to navigate. Several domains of transition must be addressed, such as
education and employment, health and living, finances and independence, and
social and community life. Specific issues to manage include transitioning to an
adult healthcare provider, determining the need for decision-making assistance
(e.g., guardianship, medical power of attorney), securing government benefits
after aging out of youth-based programs (e.g., SSI, medical assistance), agreeing
on the optimal housing situation, applying for state disability assistance
programs, and addressing caretaker estate planning as it applies to the individual
with ID (e.g., special needs trusts).
Following graduation from high school, options for continued education or
entry into the workforce should be thoroughly considered, with the greater goal
of ultimate community-based employment. Although employment is a critical
element of life adaptation for persons with ID, only 15% are estimated to have
jobs, with significant gaps in pay and compensation compared to workers
without disability. Early planning and expansion of opportunities can help to
reduce barriers to employment. Post–secondary education possibilities might
involve community college or vocational training. Employment selection should
be “customized” to the individual's interests and abilities. Options may include
participation in competitive employment, supported employment, high school–
to–work transition programs, job-coaching programs, and consumer-directed
voucher programs.
Prognosis
In children with severe ID, the prognosis is often evident by early childhood.
Mild ID might not always be a lifelong disorder. Children might meet criteria for
GDD at an early age, but later the disability can evolve into a more specific
developmental disorder (communication disorder, autism, specific learning
disability, or borderline normal intelligence). Others with a diagnosis of mild ID
during their school years may develop sufficient adaptive behavior skills that
they no longer fit the diagnosis as adolescents or young adults, or the effects of
maturation and plasticity may result in children moving from one diagnostic
category to another (from moderate to mild ID). Conversely, some children who
have a diagnosis of a specific learning disability or communication disorder
might not maintain their rate of cognitive growth and may fall into the range of
ID over time.
The apparent higher prevalence of ID in low- and middle-income countries is
of concern given the limitations in available resources. Community-based
rehabilitation (CBR) is an effort promoted by WHO over the past 4 decades as
a means of making use of existing community resources for persons with
disabilities in low-income countries with the goal of increasing inclusion and
participation within the community. CBR is now being implemented in >90
countries, although the efficacy of such programs has not been established.
The long-term outcome of persons with ID depends on the underlying cause,
degree of cognitive and adaptive deficits, presence of associated medical and
developmental impairments, capabilities of the families, and school and
community supports, services, and training provided to the child and family
(Table 53.7 ). As adults, many persons with mild ID are capable of gaining
economic and social independence with functional literacy, but they may need
periodic supervision (especially when under social or economic stress). Most
live successfully in the community, either independently or in supervised
settings.
Table 53.7
For persons with moderate ID, the goals of education are to enhance adaptive
abilities and “survival” academic and vocational skills so they are better able to
live and function in the adult world (Table 53.7 ). The concept of supported
employment has been very beneficial to these individuals; the person is trained
by a coach to do a specific job in the setting where the person is to work,
bypassing the need for a “sheltered workshop” experience and resulting in
successful work adaptation in the community. These persons generally live at
home or in a supervised setting in the community.
As adults, people with severe to profound ID usually require extensive to
pervasive supports (Table 53.7 ). These individuals may have associated
impairments, such as cerebral palsy, behavioral disorders, epilepsy, or sensory
impairments, that further limit their adaptive functioning. They can perform
simple tasks in supervised settings. Most people with this level of ID can live in
the community with appropriate supports.
The life expectancy of people with mild ID is similar to the general
population, with a mean age at death in the early 70s. However, persons with
severe and profound ID have a decreased life expectancy at all ages, presumably
from associated serious neurologic or medical disorders, with a mean age at
death in the mid-50s. Given that persons with ID are living longer and have high
rates of comorbid health conditions in adulthood (e.g., obesity, hypertension,
diabetes), ID is now one of the costliest ICD-10 diagnoses, with an average
lifetime cost of 1-2 million dollars per person. Thus the priorities for
pediatricians are to improve healthcare delivery systems during childhood,
facilitate the transition of care to adult providers, and ensure high-quality,
integrated community-based services for all persons with ID.
53.1
Intellectual Disability With
Regression
Bruce K. Shapiro, Meghan E. O'Neill
Alexander disease
Mitochondrial myopathy, encephalopathy, lactic acidosis, stroke
Progressive infantile poliodystrophy (Alpers disease)
Subacute necrotizing encephalomyelopathy (Leigh disease)
Trichopoliodystrophy (Menkes disease)
Neurocutaneous Syndromes
Chediak-Higashi syndrome
Neurofibromatosis*
Tuberous sclerosis*
Progressive Hydrocephalus *
Other Disorders of White Matter
Infectious Disease
Adrenoleukodystrophy
Alexander disease
Cerebrotendinous xanthomatosis
Progressive cavitating leukoencephalopathy
Other Diseases
Wilson disease
Friedreich ataxia
Pantothenate kinase neurodegeneration
Neurodegeneration with brain iron accumulation
Bibliography
American Academy of Pediatrics, Committee on Children with
Disabilities. Pediatrician's role in the development and
implementation of an Individualized Education Plan (IEP)
and/or an Individual Family Service Plan (IFSP). Pediatrics .
1999;104:124–127.
American Association on Intellectual and Developmental
Disabilities. Definition, classification, and systems of
supports . [Washington, DC] 2010 [AAIDD].
American Psychiatric Association. Diagnostic and statistical
manual of mental disorders . [ed 5, Arlington, VA] 2013
[American Psychiatric Publishing].
Battaglia A, Hoyme HE, Dallapiccola B, et al. Further
delineation of deletion 1p36 syndrome in 60 patients: a
recognizable phenotype and common cause of developmental
delay and mental retardation. Pediatrics . 2008;121:404–410.
Cleary MA, Green A. Developmental delay: when to suspect
and how to investigate for an inborn error of metabolism.
Arch Dis Child . 2005;90(11):1128–1132.
Council on Children with Disabilities, Section on
Developmental Behavioral Pediatrics, Bright Futures Steering
Committee, Medical Home Initiatives for Children with
Special Needs Project Advisory Committee. Identifying
infants and young children with developmental disorders in
the medical home: an algorithm for developmental
surveillance and screening. Pediatrics . 2006;118:405–420.
Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of
mental retardation: recommendations of a Consensus
Conference: American College of Medical Genetics. Am J
Med Genet . 1977;72:468–477.
De Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic
exome sequencing in persons with severe intellectual
disability. N Engl J Med . 2012;367.
Gecz J, Haan E. New mutations and sporadic intellectual
disability. Lancet . 2012;380(9854):1630–1631.
Johnson CP, Walker WO Jr, Palomo-Gonzales SA, et al. Mental
retardation: diagnosis, management, and family support. Curr
Probl Pediatr Adolesc Health Care . 2006;36:123–171.
Martin CL, Ledbetter DH. Chromosomal microarray testing for
children with unexplained neurodevelopmental disorders.
JAMA . 2017;317(24):2545–2546.
Maulik PK, Mascarenhas MN, Mathers CD, et al. Prevalence of
intellectual disability: a meta-analysis of population-based
studies. Res Dev Disabil . 2011;32(2):419–436.
Michelson DJ, Shevell MI, Sherr EH, et al. Evidence report.
Genetic and metabolic testing on children with global
developmental delay: report of the Quality Standards
Subcommittee of the American Academy of Neurology and
the Practice Committee of the Child Neurology Society.
Neurology . 2011;77(17):1629–1635.
Moeschler JB, Shevell M, American Academy of Pediatrics
Committee on Genetics. Comprehensive evaluation of the
child with intellectual disability or global developmental
delays. Pediatrics . 2014;134:e903–e918.
Rauch A, Wieczorek D, Graf E, et al. Range of genetic
mutations associated with severe non-syndromic sporadic
intellectual disability: an exome sequencing study. Lancet .
2012;380(9854):1674–1682.
Robertson J, Emerson E, Hatton C, et al. Efficacy of
community-based rehabilitation for children with or at
significant risk of intellectual disabilities in low- and middle-
income countries: a review. J Appl Res Intellect Disabil .
2012;25(2):143–154.
Saha S, Barnett AG, Foldi C, et al. Advanced paternal age is
associated with impaired neurocognitive outcomes during
infancy and childhood. PLoS Med . 2009;6:e40.
Shapiro BK, Batshaw ML. Developmental delay and
intellectual disability. Batshaw ML, Pellegrino L, Roizen NJ.
Children with disabilities . ed 7. Paul H Brookes: Baltimore;
2013:291–306.
Shevell M, Ashwal S, Donley D, et al. Practice parameter:
evaluation of the child with global developmental delay.
Neurology . 2003;60:367–380.
Stevenson RE, Schwartz CE. X-linked intellectual disability:
unique vulnerability of the male genome. Dev Disabil Res
Rev . 2009;15:361–368.
Sundaram S, Huq AH, Hsia T, et al. Exome sequencing and
diffusion tensor imaging in developmental disabilities.
Pediatr Res . 2014;75(3):443–447.
Tarailo-Graovac M, Shyr C, Ross CJ, et al. Exome sequencing
and the management of neurometabolic disorders. N Engl J
Med . 2016;374(23):2246–2255.
Tarini BA, Zikmund-Fisher BJ, Saal HM, et al. Primary care
providers' initial evaluation of children with global
developmental delay: a clinical vignette study. J Pediatr .
2015;167:1404–1408.
Tarpey PS, Smith R, Pleasance E, et al. A systematic, large-
scale resequencing screen of X-chromosome coding exons in
mental retardation. Nat Genet . 2009;41(5):535–543.
Valente EM, Ferraris A, Dallapiccola B. Genetic testing for
paediatric neurological disorders. Lancet . 2008;7:1113–1126.
Van Karnebeek CD, Scheper FY, Abeling NG, et al. Etiology of
mental retardation in children referred to a tertiary care
center: a prospective study. Am J Ment Retard .
2005;110(4):253–267.
Van Karnebeek CD, Shevell M, Zschocke J, et al. The metabolic
evaluation of the child with an intellectual developmental
disorder: diagnostic algorithm for identification of treatable
causes and new digital resource. Mol Genet Metab .
2014;111:428–438.
Van Karnebeek CD, Stockler S. Treatable inborn errors of
metabolism causing intellectual disability: a systematic
literature review. Mol Genet Metab . 2012;105:368–381.
Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for
mental retardation. Nat Genet . 2010;42(12):1109–1112.
World Health Organization. Definition: intellectual disability .
http://www.euro.who.int/en/what-we-do/health-
topics/noncommunicable-diseases/mental-
health/news/news/2010/15/childrens-right-to-family-
life/definition-intellectual-disability .
World Health Organization. Mental retardation . [In
International Statistical Classification of Diseases and
Related Health Problems, 10th revision, Geneva] 2011
[WHO].
CHAPTER 54
Definition
Autism spectrum disorder (ASD) is a neurobiologic disorder with onset in
early childhood. The key features are impairment in social communication and
social interaction accompanied by restricted and repetitive behaviors. The
presentation of ASD can vary significantly from one individual to another, as
well as over the course of development for a particular child. There is currently
no diagnostic biomarker for ASD. Accurate diagnosis therefore requires careful
review of the history and direct observation of the child's behavior.
From the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,
(Copyright 2013). American Psychiatric Association, pp 50–51.
Table 54.2
Associated Features of Autism Not in DSM-5
Criteria
For version with full references, see Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition, Washington DC, 2013, American Psychiatric
Association. Adapted from Lai MC, Lombardo MV, Baron-Cohen S: Autism,
Lancet 383:896–910, 2014.
Language delay (in babbling or using words; e.g., using <10 words by age
2 yr).
Regression in, or loss of, use of speech.
Spoken language (if present) may include unusual features, such as
vocalizations that are not speech-like; odd or flat intonation; frequent
repetition of set words and phrases (echolalia); reference to self by name
or “you” or “she” or “he” beyond age 3 yr.
Reduced and/or infrequent use of language for communication; e.g., use of
single words, although able to speak in sentences.
Responding to Others
Adapted from Baird G, Douglas HR, Murphy MS: Recognizing and diagnosing
autism in children and young people: summary of NICE guidance. BMJ
343:d6360, 2011, Box 1, p 901.
Social-Emotional Reciprocity
Reduced social interactions in ASD may range from active avoidance or reduced
social response to having an interest in, but lacking ability to initiate or sustain,
an interaction with peers or adults. A young child with ASD may not respond
when his name is called, may exhibit limited showing and sharing behaviors, and
may prefer solitary play. In addition, the child may avoid attempts by others to
play and may not participate in activities that require taking turns, such as peek-
a-boo and ball play. An older child with ASD may have an interest in peers but
may not know how to initiate or join in play. The child may have trouble with
the rules of conversation and may either talk at length about an area of interest or
abruptly exit the interaction. Younger children often have limited capacity for
imaginative or pretend play skills. Older children may engage in play but lack
flexibility and may be highly directive to peers. Some children with ASD
interact well with adults but struggle to interact with same-age peers.
Insistence on Sameness
Children with ASD have difficulty tolerating transitions or change. They may
insist on certain routines or schedules and can become very distressed with
unexpected events or new situations. They may repeat scripts from shows or
movies or watch the same portion of a video repeatedly. Intolerance for change
causes significant impairment and impact on child and family function.
Restricted Interests
This symptom may manifest as intense interests that seem out of the norm in
comparison to same-age peers. Younger children may play with a limited range
of toys or may insist on retaining a small object in each hand. Older children
may have a strong preference for a particular story or movie. The area of interest
may be shared by peers (e.g., Disney movies, Legos, Thomas the Train) but
unusual in its intensity. Other affected children may have interests that are both
intense and odd, such as an interest in brands of vehicles, license plate numbers,
or fans and heating systems. These interests interfere with social interactions; a
child may only want to talk about her area of interest or may insist that peers act
out a particular story in a rigid and inflexible manner.
Table 54.4
Table 54.5
Common Co-occurring Conditions in Autism Spectrum
Disorder (ASD)
INDIVIDUALS
WITH
COMORBIDITY COMMENTS
AUTISM
AFFECTED
DEVELOPMENTAL DISORDERS
Intellectual ~45% Prevalence estimate is affected by the diagnostic boundary and
disability definition of intelligence (e.g., whether verbal ability is used as a
criterion).
In individuals, discrepant performance between subtests is common.
Language disorders Variable In DSM-IV, language delay was a defining feature of autism (autistic
disorder), but is no longer included in DSM-5.
An autism-specific language profile (separate from language
disorders) exists, but with substantial interindividual variability.
Attention- 28–44% In DSM-IV, not diagnosed when occurring in individuals with autism, but
deficit/hyperactivity no longer so in DSM-5.
disorder
Tic disorders 14–38% ~6⋅5% have Tourette syndrome.
Motor abnormality ≤79% See Table 54.2 .
GENERAL MEDICAL DISORDERS
Epilepsy 8–35% Increased frequency in individuals with intellectual disability or
genetic syndromes.
Two peaks of onset: early childhood and adolescence.
Increases risk of poor outcome.
Gastrointestinal 9–70% Common symptoms include chronic constipation, abdominal pain,
problems chronic diarrhea, and gastroesophageal reflux.
Associated disorders include gastritis, esophagitis, gastroesophageal
reflux disease, inflammatory bowel disease, celiac disease, Crohn
disease, and colitis.
Immune ≤38% Associated with allergic and autoimmune disorders.
dysregulation
Genetic disorders 10–20% Collectively called syndromic autism.
Examples include fragile X syndrome (21–50% of individuals
affected have autism), Rett syndrome (most have autistic features but
with profiles different from idiopathic autism), tuberous sclerosis
complex (24–60%), Down syndrome (5–39%), phenylketonuria (5–
20%), CHARGE syndrome* (15–50%), Angelman syndrome (50–
81%), Timothy syndrome (60–70%), and Joubert syndrome (~40%).
Sleep disorders 50–80% Insomnia is the most common.
PSYCHIATRIC DISORDERS
Anxiety ~40% Common across all age-groups.
Most common are social anxiety disorder (13–29% of individuals
with autism) and generalized anxiety disorder (13–22%).
High-functioning individuals are more susceptible (or symptoms are
more detectable).
Depression 12–70% Common in adults, less common in children.
High-functioning adults who are less socially impaired are more
susceptible (or symptoms are more detectable).
Obsessive- 7–24% Shares the repetitive behavior domain with autism that could cut
compulsive disorder across nosologic categories.
(OCD) Important to distinguish between repetitive behaviors that do not
involve intrusive, anxiety-causing thoughts or obsessions (part of
autism) and those that do (and are part of OCD).
Psychotic disorders 12–17% Mainly in adults.
Most commonly recurrent hallucinosis.
High frequency of autism-like features (even a diagnosis of ASD)
preceding adult-onset (52%) and childhood-onset schizophrenia (30–
50%).
Substance use ≤16% Potentially because individual is using substances as self-medication to
disorders relieve anxiety.
Oppositional 16–28% Oppositional behaviors could be a manifestation of anxiety, resistance to
defiant disorder change, stubborn belief in the correctness of own point of view, difficulty
seeing another's point of view, poor awareness of the effect of own
behavior on others, or no interest in social compliance.
Eating disorders 4–5% Could be a misdiagnosis of autism, particularly in females, because both
involve rigid behavior, inflexible cognition, self-focus, and focus on
details.
PERSONALITY DISORDERS †
Paranoid 0–19% Could be secondary to difficulty understanding others' intentions and
personality disorder negative interpersonal experiences.
Schizoid 21–26% Partly overlapping diagnostic criteria.
personality disorder
Schizotypal 2–13% Some overlapping criteria, especially those shared with schizoid
personality disorder personality disorder.
Borderline 0–9% Could have similarity in behaviors (e.g., difficulties in interpersonal
personality disorder relationships, misattributing hostile intentions, problems with affect
regulation), which requires careful differential diagnosis.
Could be a misdiagnosis of autism, particularly in females.
Obsessive- 19–32% Partly overlapping diagnostic criteria.
compulsive
personality disorder
Avoidant 13–25% Could be secondary to repeated failure in social experiences.
personality disorder
BEHAVIORAL DISORDERS
Aggressive ≤68% Often directed toward caregivers rather than noncaregivers.
behaviors Could be a result of empathy difficulties, anxiety, sensory overload,
disruption of routines, and difficulties with communication.
Self-injurious ≤50% Associated with impulsivity and hyperactivity, negative affect, and
behaviors lower levels of ability and speech.
Could signal frustration in individuals with reduced communication,
as well as anxiety, sensory overload, or disruption of routines.
Could also become a repetitive habit.
Could cause tissue damage and need for restraint.
Pica ~36% More likely in individuals with intellectual disability.
Could be a result of a lack of social conformity to cultural categories
of what is deemed edible, or sensory exploration, or both.
Suicidal ideation or 11–14% Risks increase with concurrent depression and behavioral problems, and
attempt after being teased or bullied.
*Coloboma of the eye; heart defects; atresia of the choanae; retardation of growth and
development, or both; genital and urinary abnormalities, or both; and ear abnormalities and
deafness.
†
Particularly in high-functioning adults.
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition ; DSM-5, Diagnostic
and Statistical Manual of Mental Disorders, Fifth edition.
Adapted from Lai MC, Lombardo MV, Baron-Cohen S: Autism, Lancet 383:896–910, 2014.
Epidemiology
The prevalence of ASD is estimated at 1 in 59 persons by the U.S. Centers for
Disease Control and Prevention (CDC). The prevalence increased significantly
over the past 25 years, primarily because of improved diagnosis and case finding
as well as inclusion of less severe presentations within the autism spectrum.
There is a 4:1 male predominance. The prevalence is increased in siblings (up to
10% recurrence rate) and particularly in identical twins. There are no racial or
ethnic differences in prevalence. Individuals from racial minorities and lower
socioeconomic status are at risk for later diagnosis.
Etiology
The etiology of ASD is thought to result from disrupted neural connectivity and
is primarily impacted by genetic variations affecting early brain development.
Animal models and studies of individuals with ASD indicate changes in brain
volume and neural cell density in the limbic system, cerebellum, and
frontotemporal regions. One study documented changes in early brain
development, characterized as “hyperexpansion of cortical surface area,” at age
6-12 mo on brain MRI, which correlated with later development of impaired
social skills. Functional studies show abnormalities of processing information,
particularly related to foundational social skills such as facial recognition. The
disruptions in early brain development likely are responsive the treatment. Early
developmental therapies in young children with ASD have demonstrated the
capacity for normalization of electrophysiologic response to visual stimuli,
including faces.
Numerous genes involved in brain development and synaptic function have
been associated with ASD. Mutations that include large genetic deletions or
duplications and small sequencing changes have been implicated; these can be
inherited or occur de novo. Heterozygous mutations in genes, such as present in
deletion or duplication of 15q11.2 or 16p11.2, may have variable expression
within a family. Rare recessive mutations have been implicated in some
populations with high levels of consanguinity. Patients with a number of genetic
syndromes (e.g., fragile X, Down, Smith-Lemli-Opitz, Rett, Angelman, Timothy,
Joubert) as well as disorders of metabolism and mitochondrial function have
higher rates of ASD than the general population (Table 54.5 ).
There is also evidence for environmental contributions to ASD. Older
maternal or paternal age may increase the risk of ASD. In addition, factors
influencing the intrauterine environment, such as maternal obesity or
overweight, short interval from prior pregnancy, premature birth, and certain
prenatal infections (e.g., rubella, cytomegalovirus) are associated with ASD. An
epigenetic model is considered one explanation for the etiology; individuals with
genetic vulnerability may be more sensitive to environmental factors influencing
early brain development.
Despite frequent concerns from families that vaccines or the preservatives in
vaccines lead to ASD, there is no evidence to support this claim. Multiple
research studies and meta-analyses have failed to show an association of
vaccines with ASD.
Differential Diagnosis
The differential diagnosis of ASD is complex because many conditions in the
differential can also occur with ASD. The most important conditions to consider
in young children are language disorder (see Chapter 52 ), intellectual disability
or global developmental delay (Chapter 53 ), and hearing loss (Chapter 655 ).
Children with language disorder may have impairments in social
communication and play; their social and play skills, however, are typically on
par with their language level. In addition, they do not have associated restricted
and repetitive behavior or atypical use of language, such as scripting. The
diagnosis of social communication disorder is also distinguished from ASD by
the lack of restrictive and repetitive behaviors. Children with intellectual
disability (ID) or global developmental delay (GDD) may have delays in
social and communication skills as well as stereotyped behavior. However, social
and communication skills are typically commensurate with their cognitive and
adaptive functioning. Children with hearing loss may present with some “red
flags” for ASD, such as poor response to name. However, they typically develop
nonverbal communication and play skills as expected and do not have
stereotyped or restricted behavior patterns.
In older children, disorders of attention, learning, and mood regulation must
be considered in the differential diagnosis of ASD. Children with attention-
deficit/hyperactivity disorder (ADHD) may present with reduced eye contact
and response to name caused by poor attention rather than lack of social
awareness. Children with ADHD, however, do not have associated impairments
in shared enjoyment and social reciprocity or repetitive behaviors. Children with
social anxiety or other anxiety disorders may present with some symptoms
suggestive of ASD. Shy children may have reduced eye contact and social
initiation. Anxious children can be resistant to change and prefer familiar
routines. Children with anxiety, however, typically will have preserved social
interest and insight and will not exhibit high levels of stereotyped behaviors.
Reactive attachment disorder can be difficult to distinguish from ASD,
particularly in younger children with history of trauma. However, social
behaviors in these children generally improve with positive caretaking.
The differentiation of ASD from obsessive-compulsive disorder (OCD) ,
tics, and stereotyped behaviors can sometimes be challenging. In general,
stereotyped behaviors may be calming or preferred, whereas tics and compulsive
routines are distressing to the individual. Children with OCD have intense
interests as well as repetitive behaviors and rituals but do not have impairment in
social communication or interaction. Children with stereotypic movement
disorder will not have impaired social skills or other types of restricted and
repetitive behaviors. Children with Landau Kleffner syndrome (LKS) present
with loss of skills in language comprehension (auditory verbal agnosia) and
verbal expression (aphasia) associated with onset of epileptic seizures during
sleep (see Chapter 52 ). In contrast to ASD, children with LKS present with
typical early development followed by loss of language function at age 3-6 yr.
Comorbid Conditions
Up to 50% of individuals with ASD have intellectual disability, ranging in
severity from mild to severe (Table 54.5 ). Intellectual disability is associated
with higher rates of both identified genetic conditions and epilepsy. Children
with ASD often have associated language impairments, including delays in
expressive, receptive, and pragmatic (social) language skills. Language function
can range widely from nonverbal status to age appropriate. Gastrointestinal (GI)
problems such as constipation, esophagitis, and gastroesophageal reflux disease
(GERD) are reported in up to 70% of children with ASD. Epilepsy occurs in up
to 35% of children with ASD and presents in 2 peaks, in early childhood and in
adolescence. Epilepsy or electrical seizures without motor manifestations may be
a cause of regression in young children with ASD.
Children with ASD are at higher risk for disorders of attention, including
reduced attention for nonpreferred activities and excessive attention for preferred
activities. A subset of children will also meet full criteria for a diagnosis of
ADHD. There are higher rates of anxiety (~40%) and mood disorders in ASD,
particularly during adolescence. Children with ASD are also at increased risk for
being bullied and may present with secondary irritability, anxiety, or depression.
Sleep problems, including delayed sleep onset, frequent night waking, and
abnormal sleep architecture, are reported in 50–80% of children with ASD.
There is some evidence for baseline abnormalities in melatonin secretion. The
use of screen-based activities such as television, computers, or tablets before
bedtime can inhibit melatonin secretion. Children with ASD also have higher
rates of feeding and toileting problems resulting from resistance to change,
sensory sensitivity, and repetitive behavior patterns. Many children with ASD
have restrictive feeding patterns and food selectivity. They also have higher rates
of overweight, possibly because of diets higher in carbohydrates, reduced
physical activity, use of food rewards to regulate behavior, and side effects from
medications used for managing mood and behavior.
Disruptive behaviors such as self-injury and aggression are common in ASD
patients, but most common in individuals with lower cognitive function and
limited language. Sleep deprivation, nutritional deficits, pain, epilepsy, and
medication side effects may contribute to disruptive behaviors.
Screening
The American Academy of Pediatrics recommends screening for ASD for all
children at age 18 mo and 24 mo (see Chapter 28 ). Screening should also occur
when there is increased risk for ASD, such as a child with an older sibling who
has ASD, or concern for possible ASD. Screening can be done by parent
checklist or direct assessment. The most frequently used screening tool is the
Modified Checklist for Autism, Revised/Follow-Up Interview (MCHAT-R/FU), a
20-item parent report measure, with additional parent interview completed for
intermediate scores. The MCHAT-R/FU can be used from age 16-30 mo.
Assessment
Diagnostic assessment should include medical evaluation and assessment of the
child's cognitive, language, and adaptive function. Assessment may occur in a
single multidisciplinary visit or through a series of visits with different
developmental specialists. Multidisciplinary evaluation with clinicians who have
expertise with ASD is optimal for diagnostic accuracy and treatment planning.
Developmental-behavioral pediatricians, neurodevelopmental disability
specialists, neurologists, psychiatrists, and psychologists are qualified to make a
formal diagnosis of ASD. Other specialists, including speech-language
pathologists and occupational therapists, should also be included depending on
the child's age and the presenting concerns.
Assessment of ASD includes direct observation of the child to evaluate social
skills and behavior. Informal observation can be supplemented with structured
diagnostic tools such as the Autism Diagnostic Observation Schedule, Second
Edition (ADOS-2) and Autism Diagnostic Observation Schedule, Toddler
module (ADOS-T). These structured play-based assessments provide social
prompts and opportunities to evaluate the frequency and quality of a child's
social responsiveness to, initiation, and maintenance of social interactions; the
capacity for joint attention and shared enjoyment; the child's behavioral
flexibility; and presence of repetitive patterns of behavior. The ADOS-2 and
ADOS-T are not required for accurate diagnosis and do not stand alone, but
rather can be used to augment a careful history and observation. The Childhood
Autism Rating Scale, Second Edition (CARS-2) is a 15-item direct clinical
observation instrument that can assist clinicians in the diagnosis of ASD. The
Autism Diagnostic Interview-Revised (ADI-R) is a lengthy clinical interview tool
that is used primarily in research settings since it takes several hours to
administer. Other tools include standardized rating scales that parents and
teachers can complete to report on the child's social skills and behaviors.
Medical evaluation should include a thorough history and detailed physical
examination of the child, including direct behavioral observations of
communication and play. In addition, the examination should include
measurement of head circumference, careful evaluation for dysmorphic features,
and screening for tuberous sclerosis with Wood lamp exam. Children with ASD
should have genetic testing (described later), an audiology examination to rule
out hearing loss, and in children with pica, a lead test (Table 54.6 ).
Table 54.6
Medical and Genetic Evaluation of Children
With Autism Spectrum Disorder
Physical Examination
Second Tier
Girls with ASD should have testing for mutation in the MeCP2 gene if CMA is
normal. Boys who have hypotonia, drooling, and frequent respiratory infections
should have MeCP2 deletion/duplication testing. All individuals with ASD and a
head circumference greater than 2.5 standard deviations (SD) above the mean
should have testing for mutation in the PTEN gene because there is a risk for
hamartoma tumor disorders (Cowden, Proteus-like, Bannayan-Riley-Ruvakaba
syndromes) in these individuals. Cytogenetic testing (karyotype) has a lower
yield than CMA. Karyotype is recommended if microarray is not available and
in children with suspected balanced translocation, such as history of multiple
prior miscarriages.
Further medical diagnostic testing is indicated by the child's history and
presentation. Brain imaging is indicated in cases of microcephaly, significant
developmental regression, or focal findings on neurologic examination. Because
of the high rate (up to 25%) of macrocephaly in ASD, imaging is not indicated
for macrocephaly alone. MRI is not recommended for minor language regression
(loss of a few words) during the 2nd year of life that is often described in
toddlers with ASD. Children with concern for seizures, spells, or developmental
regression should have an electroencephalogram (EEG). Metabolic screening is
indicated for children with signs of a metabolic or mitochondrial disorder, such
as developmental regression, weakness, fatigue, lethargy, cyclic vomiting, or
seizures (see Chapters 53 and 102 ).
Treatment and Management
Educational
The primary treatment for ASD is done outside the medical setting and includes
developmental and educational programming. Numerous resources have been
developed that can help families in the complex process of treatment planning
(Table 54.7 ). Intensive behavioral therapies have the strongest evidence to date.
Earlier age at initiation of treatment and higher intensity of treatment are
associated with better outcomes. Programming must be individualized, and no
approach is successful for all children. In addition, research treatments are often
conducted with a high level of intensity and fidelity that are difficult to scale up
or reproduce in community settings. Higher cognitive, play, and joint attention
skills and lower symptom severity at baseline are predictors for better outcomes
in core symptoms, intellectual function, and language function.
Table 54.7
Autism Resources for Families
Table 54.8
Common Pharmacologic Treatments in Autism Spectrum
Disorder (ASD)
TARGET MEDICATION
EFFECTS SIDE EFFECTS MONITORING
SYMPTOM CLASS*
Hyperactivity Stimulants Decreased Activation, irritability, emotional Height, weight, BP,
and/or hyperactivity, lability, lethargy/social HR
Inattention impulsivity, improved withdrawal, stomach ache,
attention reduced appetite, insomnia,
increased stereotypy
α2 -Agonists Decreased Drowsiness, irritability, enuresis, Height, weight, BP,
hyperactivity, decreased appetite, dry mouth, HR
impulsivity, improved hypotension
attention
Selective Decreased Irritability, decreased appetite, Height, weight, BP,
norepinephrine hyperactivity, fatigue, stomach ache, nausea, HR
reuptake impulsivity, improved vomiting, racing heart rate
inhibitor attention
Anxiety Selective Decreased anxiety Activation, hyperactivity, Weight, BP, HR
serotonin inattention, sedation, change
reuptake in appetite, insomnia,
inhibitors stomach ache, diarrhea
Citalopram: prolonged QTc
interval
Irritability Atypical Decreased irritability, Somnolence, weight gain, Weight, BP, HR
antipsychotics aggression, self- extrapyramidal movements, Monitor CBC,
(risperidone, injurious behavior, drooling, tremor, dizziness, cholesterol,
aripiprazole) repetitive behavior, vomiting, gynecomastia ALT, AST,
hyperactivity prolactin,
glucose or
hemoglobin
A1c
Insomnia Melatonin Shortened sleep onset Nightmares, enuresis —
*
Specific medications names are provided in parentheses when there is a FDA-approved
indication for the use of the medication to treat the symptom in children with ASD. Further
information about these medications is available in Chapter 33 .
BP, Blood pressure; HR, heart rate; CBC, complete blood count; ALT, alanine transaminase; AST,
aspartate transaminase.
Preliminary data suggest that intranasal therapy with neuropeptide oxytocin
may improve social functioning in children with ASD, particularly those with
low pretreatment oxytocin levels.
There is evidence to support use of stimulant medication, atomoxetine and α-
agonists for ADHD in ASD. Selective serotonin reuptake inhibitors (SSRI) can
be used for anxiety and OCD and in adolescents may also be useful for
depression. Benzodiazepines may be useful for situational anxiety, for example,
triggered by dental and medical procedures or air travel. Medications used to
treat ADHD and anxiety may result in activation or irritability in ASD and
require careful monitoring.
Melatonin can be used to improve sleep onset but will not address night
waking. Clonidine or trazodone may be used for sleep onset and maintenance.
No medications are specifically labeled for treatment of insomnia in ASD.
The α-adrenergic agonists may be helpful in children who present with
significant behavioral dysregulation. There are two atypical antipsychotic
medications that have U.S. Food and Drug Administration (FDA)
recommendation for irritability and aggression in children with ASD. Both
risperidone and aripiprazole have several studies documenting efficacy for
reducing irritability, aggression, and self-injury. Secondary improvements in
attention and repetitive behavior were also noted. Side effects include weight
gain and metabolic syndrome as well as tardive dyskinesia and extrapyramidal
movements. Careful laboratory monitoring is recommended. Mood-stabilizing
antiepileptic medications have also been used to treat irritability.
Transition
Navigating a successful transition to adult care is a key role for the pediatric
provider. This process should ideally start as early as age 12-13 yr. Parents are
faced with a complex and disconnected system of diverse agencies that they
need to navigate. Use of structured-visit templates and care coordinators can
help ensure that families and their youth with ASD are able to make appropriate
decisions about secondary and postsecondary educational programming,
vocational training, guardianship, finances, housing, and medical care. High
school educational programming should include individualized and meaningful
vocational training, as well as instruction regarding sexuality, relationships,
safety and abuse prevention, finances, travel training, and general self-advocacy.
Individuals with ASD who are higher functioning will need help accessing
supports for college or postsecondary skills training and may benefit from
referral to their state vocational rehabilitative services as well as personal life
coaches or counselors. Families who have adult children with more significant
cognitive disability need information about the range of adult disability services,
how to apply for supplemental security income (SSI), and the process for
considering guardianship or medical and financial conservatorship for their adult
child. These decisions are complex and must be individualized for the adult with
ASD and the family.
Outcome
Autism spectrum disorder is a lifelong condition. Although a minority of
individuals respond so well to therapy that they no longer meet criteria for the
diagnosis, most will make progress but continue to have some impairment in
social and behavioral function as adults. Adult outcome studies are sobering,
indicating that many adults with ASD are socially isolated, lack gainful
employment or independent living, and have higher rates of depression and
anxiety. It is not clear if these data can be extrapolated to younger children
currently receiving intensive educational therapies. There is a growing network
of adult self-advocates who promote the unique strengths in individuals with
ASD. Outcome as measured by developmental progress and functional
independence is better for individuals who have higher cognitive and language
skills and lower ASD severity at initial diagnosis.
Bibliography
American Psychiatric Association. Diagnostic and statistical
manual of mental disorders . ed 5. American Psychiatric
Association: Washington, DC; 2013.
Arora M, Reichenberg A, Willfors C, et al. Fetal and postnatal
metal dysregulation in autism. Nat Commun . 2017;8:15493;
10.1038/ncomms15493 .
Broder-Fingert S, Feinberg E, Silverstein M. Music therapy for
children with autism spectrum disorders. JAMA .
2017;318(6):523–524.
Brown HK, Ray JG, Wilton AS, et al. Association between
serotonergic antidepressant use during pregnancy and autism
spectrum disorder in children. JAMA . 2017;317(15):1544–
1552.
Buie T, Campbell DB, Fuchs GJ, et al. Evaluation, diagnosis
and treatment of gastrointestinal disorders in individuals with
ASDs: a consensus report. Pediatrics . 2010;125:S1–S18.
Cuomo BM, Vaz S, Lee EAI, et al. Effectiveness of sleep-based
interventions for children with autism spectrum disorder: a
meta-synthesis. Pharmacotherapy . 2017;37(5):555–578.
Dawson G, Rogers S, Munson J, et al. Randomized, controlled
trial of an intervention for toddlers with autism: the Early
Start Denver Model. Pediatrics . 2010;125:e17.
Dove D, Warren Z, McPheeters ML, et al. Medications for
adolescents and young adults with autism spectrum disorders:
a systematic review. Pediatrics . 2012;130:717–726.
Estes A, Munson J, Rogers SJ, et al. Long-term outcomes of
early intervention in 6-year-old children with autism
spectrum disorder. J Am Acad Child Adolesc Psychiatry .
2015;54:580.
Gabriels RL, Pan Z, Dechant B, et al. Randomized controlled
trial of therapeutic horseback riding in children and
adolescents with autism spectrum disorder. J Am Acad Child
Adolesc Psychiatry . 2015;54(7):541–549.
Hazlett HC, Hongbin G, Munsell BC, et al. Early brain
development in infants at high risk for autism spectrum
disorder. Nature . 2017;542:348–353.
Johnson CP, Myers SM, American Academy of Pediatrics
Council on Children with Disabilities. Identification and
evaluation of children with autism spectrum disorders.
Pediatrics . 2007;120:1183.
Kasari C, Gulsrud AC, Wong C, et al. Randomized controlled
caregiver mediated joint engagement intervention for toddlers
with autism. J Autism Dev Disord . 2010;40:1045.
Kasari C, Gulsrud A, Freeman S, et al. Longitudinal follow-up
of children with autism receiving targeted interventions on
joint attention and play. J Am Acad Child Adolesc Psychiatry
. 2012;51:487.
Kasari C, Rotheram-Fuller E, Locke J, Gulsrud A. Making the
connection: randomized controlled trial of social skills at
school for children with autism spectrum disorders. J Child
Psychol Psychiatry . 2012;53:431.
Kaufmann WE, Kidd SA, Andrews HF, et al. Autism spectrum
disorders in fragile X syndrome: cooccurring conditions and
current treatment. Pediatrics . 2017;139(S3):S194–S206.
Klein N, Kemper KJ. Integrative approaches to caring for
children with autism. Curr Probl Pediatr Adolesc Health
Care . 2016;46:195.
Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet .
2014;383:896–910.
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J.
Autism spectrum disorder. Lancet . 2018;392:508–518.
Malow BA, Katz T, Reynolds A, et al. Sleep difficulties and
medications in children with autism spectrum disorders: a
registry study. Pediatrics . 2016;137:S98–S104.
McGuire K, Fung LK, Hagopian L, et al. Irritability and
problem behavior in autism spectrum disorder: a practice
pathway for pediatric primary care. Pediatrics .
2016;137:S136–S148.
Miller M, Iosif AM, Hill M, et al. Response to name in infants
developing autism spectrum disorder: a prospective study. J
Pediatr . 2017;183:141–146.
Myers SM, Johnson CP, American Academy of Pediatrics
Council on Children with Disabilities. Management of
children with autism spectrum disorders. Pediatrics .
2007;120:1162.
Parker KJ, Oztan O, Libove RA, et al. Intranasal oxytocin
treatment for social deficits and biomarkers of response in
children with autism. Proc Natl Acad Sci U S A .
2017;114(30):8119–8124.
Pickles A, LeCouteur A, Leadbitter K, et al. Parent-mediated
social communication therapy for young children with autism
(PACT): long-term follow-up of a randomized controlled
trial. Lancet . 2016;388:2501–2509.
Pierce K, Courchesne E, Bacon E. To screen or not to screen
universally for autism is not the questions: why the task force
got it wrong. J Pediatr . 2016;176:182–194.
Sathe N, Andrews JC, McPheeters ML, Warren ZE. Nutritional
and dietary interventions for autism spectrum disorder: a
systematic review. Pediatrics . 2017;139(6):e20170346.
Schaefer GB, Mendelsohn NJ, Professional Practice and
Guidelines Committee. Clinical genetics evaluation in
identifying the etiology of autism spectrum disorders: 2013
guideline revisions. Genet Med . 2013;15:399.
Schendel DE, Overgaard M, Christiansen J, et al. Association of
psychiatric and neurologic comorbidity with mortality among
persons with autism spectrum disorder in a Danish
population. JAMA Pediatr . 2016;170(3):243–250.
Schreibman L, Dawson G, Stahmer AC, et al. Naturalistic
developmental behavioral interventions: empirically validated
treatments for autism spectrum disorder. J Autism Dev Disord
. 2015;45:2411.
Shen MD, Kim SH, McKinstry RG, et al. Increased extra-axial
cerebrospinal fluid in high-risk infants who later develop
autism. Biol Psychiatry . 2017;82(3):186–193.
Siegel M, Beaulieu AA. Psychotropic medications in children
with autism spectrum disorders: a systematic review and
synthesis for evidence-based practice. J Autism Dev Disord .
2012;42(8):1592–1605.
Sigafoos J, Waddington H. 6 year follow-up supports early
autism intervention. Lancet . 2016;388:2454–2455.
Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not
associated with autism: an evidence based meta-analysis of
case-control and cohort studies. Vaccine . 2014;32:3623–
3629.
Vasa RA, Mazurek MO, Mahajan R, et al. Assessment and
treatment of anxiety in youth with autism spectrum disorders.
Pediatrics . 2016;137:S115–S123.
Volkmar F, Siegel M, Woodbury-Smith M, American Academy
of Child and Adolescent Psychiatry (AACAP) Committee on
Quality Issues (CQI), et al. Practice parameter for the
assessment and treatment of children and adolescents with
autism spectrum disorders. J Am Acad Child Adolesc
Psychiatry . 2014;53(2):237–257.
Warren Z, McPheeters ML, Sathe N, et al. A systematic review
of early intensive intervention for autism spectrum disorders.
Pediatrics . 2011;127:e1303–e1311.
Warren Z, Veenstra-VanderWeele J, Stone W, et al. Therapies
for children with autism spectrum disorders . [AHRQ Pub No
11-EHC029-ER] Agency for Healthcare Research and
Quality: Rockville, MD; 2011:102.
Weitlauf AS, McPheeters ML, Peters B, et al. Therapies for
children with autism spectrum disorder: behavioral
interventions update . [Comparative Effectiveness Review No
137] Agency for Healthcare Research and Quality: Rockville,
MD; 2014.
Weitlauf AS, Sathe N, McPheeters ML, Warren ZE.
Interventions targeting sensory challenges in autism spectrum
disorder: a systematic review. Pediatrics .
2017;139(6):e2017347.